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An unfolded protein-induced
conformational switch activates
mammalian IRE1
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Feixia Chu2, Peter Walter1*
1Department of Biochemistry and Biophysics, Howard Hughes Medical Institute,
University of California, San Francisco, San Francisco, United States; 2Department of
Molecular, Cellular, and Biomedical Sciences, University of New Hampshire,
Durham, United States
Abstract The unfolded protein response (UPR) adjusts the cell’s protein folding capacity in the
endoplasmic reticulum (ER) according to need. IRE1 is the most conserved UPR sensor in eukaryotic
cells. It has remained controversial, however, whether mammalian and yeast IRE1 use a common
mechanism for ER stress sensing. Here, we show that similar to yeast, human IRE1a’s ER-lumenal
domain (hIRE1a LD) binds peptides with a characteristic amino acid bias. Peptides and unfolded
proteins bind to hIRE1a LD’s MHC-like groove and induce allosteric changes that lead to its
oligomerization. Mutation of a hydrophobic patch at the oligomerization interface decoupled
peptide binding to hIRE1a LD from its oligomerization, yet retained peptide-induced allosteric
coupling within the domain. Importantly, impairing oligomerization of hIRE1a LD abolished IRE1’s
activity in living cells. Our results provide evidence for a unifying mechanism of IRE1 activation that
relies on unfolded protein binding-induced oligomerization.
DOI: https://doi.org/10.7554/eLife.30700.001
Introduction
Protein-folding homeostasis is critical for proper cell function. Accordingly, cells evolved surveillance
mechanisms to monitor protein-folding status and elicit adaptive responses to adjust protein-folding
capacity according to need (Balchin et al., 2016; Bukau et al., 2006; Walter and Ron, 2011). In the
endoplasmic reticulum (ER), where the majority of transmembrane and soluble secretory proteins
fold and mature, protein-folding homeostasis is ensured by a network of signaling pathways collec-
tively known as the unfolded protein response (UPR) (Walter and Ron, 2011). In metazoans, pertur-
bations leading to the accumulation of mis- or unfolded proteins in the ER are recognized as ‘ER
stress’ by three unique ER-resident UPR sensors, IRE1, PERK and ATF6 (Cox et al., 1993; Cox and
Walter, 1996; Harding et al., 2000; Niwa et al., 1999; Sidrauski and Walter, 1997;
Tirasophon et al., 2000; Walter and Ron, 2011; Yoshida et al., 1998; Yoshida et al., 2001). These
sensors transmit information about the protein-folding status in the ER and drive gene expression
programs that modulate both the protein-folding load and folding capacity of the ER. If ER stress
remains unmitigated, the UPR induces pro-apoptotic pathways, thereby placing the network at the
center life-or-death decisions that affect the progression of numerous diseases (Bi et al., 2005;
Feldman et al., 2005; Lin et al., 2007; Lu et al., 2014; Vidal et al., 2012; Walter and Ron, 2011;
Zhang and Kaufman, 2008).
IRE1 drives the most conserved branch of the UPR, which exhibits remarkably similar mechanistic
aspects shared between yeast and mammals (Arago´n et al., 2009; Korennykh et al., 2009;
Li et al., 2010). In mammals, IRE1 exists in two isoforms, a and b. IRE1a is ubiquitously expressed,
Karago¨z et al. eLife 2017;6:e30700. DOI: https://doi.org/10.7554/eLife.30700 1 of 29
RESEARCH ARTICLE
whereas IRE1b expression is restricted to gastrointestinal and respiratory tracts (Bertolotti et al.,
2001; Tsuru et al., 2013). Both IRE1 orthologs are trans-membrane kinase/nucleases that oligomer-
ize in the ER-membrane in response to ER stress (Arago´n et al., 2009; Li et al., 2010). Oligomeriza-
tion is crucial for IRE1 activation as it allows for trans-autophosphorylation and allosteric activation of
its endonuclease domain, which for IRE1a then initiates the unconventional splicing of the XBP1
mRNA (Arago´n et al., 2009; Cox et al., 1993; Cox and Walter, 1996; Korennykh et al., 2009;
Li et al., 2010; Sidrauski and Walter, 1997; Yoshida et al., 1998; Yoshida et al., 2001). Spliced
XBP1 mRNA encodes the transcription factor XBP1s, which activates the transcription of several tar-
get genes involved in restoring ER homeostasis (Acosta-Alvear et al., 2007; Lee et al., 2003). While
the XBP1 mRNA is the only known splicing target of IRE1, active IRE1 can also cleave ER-localized
mRNAs in a process known as regulated IRE1-dependent decay of messenger RNAs (RIDD), which
serves to limit the amount of client proteins entering the ER, thus helping alleviate the folding stress
(Hollien et al., 2009; Hollien and Weissman, 2006).
Two alternative models are used to describe how IRE1’s lumenal domain senses ER stress: a
recent model where unfolded proteins act directly as activating ligands and an earlier model where
IRE1 lumenal domain is indirectly activated through dissociation of the ER-chaperone BiP.
The direct activation model emerged from the crystal structure of the core lumenal domain (cLD)
from S. cerevisiae IRE1 (yIRE1; ‘y’ for yeast), where yIRE1 cLD dimers join via a 2-fold symmetric
interface IF1L (‘L’ for lumenal). A putative peptide-binding groove that architecturally resembles that
of the major histocompatibility complexes (MHCs) extends across this interface (Credle et al.,
2005). yIRE1 selectively binds a misfolded mutant of carboxypeptidase Y (Gly255Arg, CPY*) in vivo,
and purified yIRE1 cLD directly interacts with peptides in vitro, leading to its oligomerization. Taken
together, these observations support the model that direct binding of unfolded proteins in the ER
lumen to IRE1 induces its oligomerization leading to IRE1 activation (Gardner and Walter, 2011).
eLife digest Proteins are long string-like molecules that fold into specific three-dimensional
shapes. Most proteins that a cell uses to communicate with its environment are folded within a part
of the cell called the endoplasmic reticulum. Dedicated sensor proteins in this cellular compartment
track this process to make sure that it continues to meet the cell’s demand for protein folding. If it
cannot meet the demand, unfolded or poorly folded proteins build up, which stresses the cell.
IRE1 is a sensor protein that detects stress in the endoplasmic reticulum. It is found in a range of
organisms from yeast to humans, where it spans the membrane that encloses the endoplasmic
reticulum. When unfolded proteins accumulate, IRE1 proteins come together and form so-called
oligomers. The IRE1 oligomers then become active and send signals outside of the endoplasmic
reticulum. These signals adjust the cell’s protein-folding capacity according to its needs at that time.
The yeast version of IRE1 directly recognizes unfolded proteins in the endoplasmic reticulum. Yet,
its human counterpart was found to have a different three-dimensional structure, which suggested
that it might use a different mechanism to detect the stress.
Now, Karago¨z et al. show that, as in yeast, the sensor part of human IRE1 does indeed bind to
unfolded proteins directly. This binding causes this part of the protein to engage other copies of
IRE1 and form the oligomers. To understand this interaction in more detail, Karago¨z et al. used a
technique called nuclear magnetic resonance spectroscopy to monitor changes in the shape of
proteins. These observations revealed that binding to an unfolded protein causes other parts of
IRE1 protein to change shape. In turn, these shape changes act as a switch that causes the
oligomers to form. Stopping the sensor domains from forming oligomers inactivated the IRE1
protein in mammalian cells; this rendered IRE1 unresponsive to stress within the endoplasmic
reticulum.
The regulation of IRE1 affects many health disorders, including diabetes, cancer and
neurodegenerative diseases. By showing that unfolded proteins switch IRE1 into its active,
oligomeric state, these findings might lead to new approaches to manipulate IRE1’s activity with
small molecules to help to treat these diseases.
DOI: https://doi.org/10.7554/eLife.30700.002
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Due to structural differences between human and yeast IRE1 lumenal domains, it is not yet clear if
this mechanism is also used by mammalian IRE1. Although the crystal structure of human IRE1a
(hIRE1a) cLD displays conserved structural elements in its core, there are several notable differences
between the crystal structures of human and yeast IRE1 cLD known to date (Figure 1). First, the heli-
ces flanking the groove in yIRE1 cLD are too closely juxtaposed in the human structure to allow for-
mation of the MHC-like groove present in the yeast (Zhou et al., 2006). Second, the yIRE1 cLD
structure displays a second interface, IF2L, which provides contacts for higher order oligomerization,
which was experimentally validated to be indispensable for yIRE1 activation in vivo (Figure 1). In the
yIRE1 cLD, an a-helix–turn region forms an important element in IF2L making contacts with the
incomplete b-propeller in the neighboring protomer. Notably, the residues corresponding to the a-
helix–turn are not resolved in the hIRE1a cLD crystal structure (aa V307-Y358). Instead, hIRE1a cLD
has two other symmetry mates in addition to the dimerization interface, which appear to be crystal
lattice contacts that are predicted to be too energetically unstable to form biologically important
oligomerization interfaces (Zhou et al., 2006). Indeed, the equivalent of an IF2L cannot form in the
depicted hIRE1a cLD structure because of a steric hindrance from a prominent a-helix (‘aB helix’; aa
V245-I263) that is absent in yIRE1 cLD (Figure 1) (Zhou et al., 2006).
The structural differences between IRE1 orthologs were cast to support the indirect model of
IRE1 activation in higher eukaryotes (Zhou et al., 2006). This model poses that due to the aforemen-
tioned structural differences—rather than direct unfolded protein binding—it is the reversible disso-
ciation of the ER-resident Hsp70-type chaperone BiP from IRE1’s lumenal domain the main driving
force regulating hIRE1a activity (Zhou et al., 2006). According to this view, titration of BiP to
unfolded proteins upon ER stress licenses IRE1 activation (Bertolotti et al., 2000; Carrara et al.,
2015; Oikawa et al., 2009; Zhou et al., 2006). In yeast, however, this view has been experimentally
refuted (Kimata et al., 2004; Pincus et al., 2010).
Considering the degree of conservation at various features of IRE1 mechanism of action from
yeast to mammals, we favor the unifying direct activation model. Such model finds support in the
notion that all structures adopted by a protein in a crystal lattice represent a singular snapshot of
many possible conformational states. Therefore, it is entirely plausible that human and yeast IRE1
cLD use a common mechanism of activation and that the divergent structures aforementioned repre-
sent different states in a spectrum of possible conformational states that the IRE1 cLD from any spe-
cies could assume. In this scenario, the crystal structure of hIRE1a cLD represents a ‘closed’
conformation that can shift towards an ‘open’ state to allow peptide binding in the MHC-like groove
that is apparent in the structure of the yeast ortholog (Video 1) (Gardner et al., 2013; Gardner and
IF2L
IF1L
yeast IRE1 cLD
 α−helix-turn
incomplete β−propeller
human IRE1α cLD
pdb: 2be1
aaV307-Y358 
IF1L
αB helix
pdb: 2hz6
Figure 1. Human and yeast IRE1 cLD’s crystal structures display distinct features. The aB helix in hIRE1a cLD structure (pdb: 2hz6) , the helix-turn region
and the incomplete b-propeller in yIRE1 cLD (pdb: 2be1) structure are indicated with arrows. The interfaces IF1L and IF2L and the unresolved dynamic
region (aaV307-Y358) in hIRE1a cLD crystal structure are depicted with dashed lines. The distance between the helices surrounding the groove in yIre1
and hIRE1a cLD is depicted with red arrows.
DOI: https://doi.org/10.7554/eLife.30700.003
Karago¨z et al. eLife 2017;6:e30700. DOI: https://doi.org/10.7554/eLife.30700 3 of 29
Research article Biochemistry Biophysics and Structural Biology
Walter, 2011). As such, this model predicts spe-
cific outcomes that can be experimentally
tested. Specifically, that (i) human IRE1 a cLD
can bind to unfolded polypeptides, (ii) unfolded
polypeptide binding stabilizes the open confor-
mation of the hIRE1a cLD, and (iii) the open con-
formation of hIRE1a cLD favors its
oligomerization.
Here, we used complementary biochemical
and structural approaches to experimentally
explore the mechanism of human IRE1a activa-
tion. We show that hIRE1a cLD—just like its
yeast ortholog—directly binds select peptides
with a characteristic amino acid bias. State-of-
the-art NMR experiments that probe dynamic
conformational states further support an activa-
tion mechanism involving peptide binding to the
MHC-like groove and stabilizing the open con-
formation of hIRE1a cLD. Moreover, we provide
insights into the mechanism that couples peptide binding and oligomerization to produce active
IRE1 oligomers. Importantly, we show by mutational analysis that lumenal domain driven oligomeri-
zation is crucial for IRE1 function in mammalian cells. Taken together, our results resolve the discrep-
ancies between existing models of IRE1 activation and supports a model in which unfolded
polypeptides can bind and directly activate human IRE1.
Results
The lumenal domain of human IRE1a binds peptides
To test whether, akin to yeast IRE1, mammalian IRE1 also binds unfolded proteins directly, we
employed peptide tiling arrays. To identify hIRE1a cLD-binding peptides, we designed tiling arrays
utilizing ER-targeted model proteins known to induce the UPR either by overproduction (proinsulin
and 8ab protein from SARS-corona virus [Scheuner et al., 2001; Sung et al., 2009]) or through
destabilizing point mutations (myelin protein zero (MPZ)). The peptide arrays were composed by til-
ing 18-mer peptides that step through the entire protein sequence, shifting by three amino acids
between adjacent spots. We incubated the peptide arrays with purified hIRE1a cLD fused N-termi-
nally to maltose-binding protein (MBP) and probed with an anti-MBP antibody. As shown in
Figure 2A (left panel), MBP-hIRE1a cLD bound a select subset of peptides on the arrays. To maxi-
mize the available sequence space, we analyzed binding of MBP-hIRE1a cLD to these peptides irre-
spective of their topological accessibility in the ER lumen. hIRE1a cLD recognized peptide
sequences found in both the ER-lumenal and cytosolic domains of MPZ, which we considered
together in our analyses to define the chemical properties of cLD peptide recognition. We found
that hIRE1a cLD-binding peptides with the top 10% binding scores were enriched in cysteine, tyro-
sine, tryptophan, and arginine (Figure 2B, Figure 2—figure supplement 1A, p<0.05). By contrast,
aspartate and glutamate were strongly disfavored, together with glutamine, valine, and serine.
IRE1 and the ER-resident chaperone BiP recognize a different subset of
peptides
At a first glance, the amino acid preferences displayed by mammalian IRE1 cLD resemble those of
the other chaperones including the ER chaperone BiP (Blond-Elguindi et al., 1993; Deuerling et al.,
2003; Flynn et al., 1991). Like BiP, hIRE1a cLD favored binding to aromatic and positively charged
residues (Blond-Elguindi et al., 1993; Otero et al., 2010). BiP is a highly abundant chaperone in the
ER lumen, whereas IRE1 is present at orders of magnitude lower levels (Ghaemmaghami et al.,
2003). Therefore, if IRE1 and BiP recognize the same regions of unfolded proteins, the peptide-
binding activity of hIRE1a cLD would depend entirely on saturation of BiP by unfolded substrate pro-
teins—a scenario difficult to reconcile with IRE1’s task of dynamically sensing ER stress. To address
Video 1. The model displaying the transition of hIRE1a
cLD from the ‘closed’ to ‘open’ state. The crystal
structure of hIRE1a cLD is used to represent (pdb:
2hz6) the closed and the hIRE1a cLD structural model
based on the yeast crystal structure (pdb: 2be1)
represents the open state. The movie is generated
using Pymol.
DOI: https://doi.org/10.7554/eLife.30700.004
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Figure 2. hIRE1a cLD binds peptides and unfolded proteins (A) Peptide arrays tiled with 18mer peptides derived from proinsulin, myelin protein zero
(MPZ), 8ab are probed with MBP-hIRE1a cLD (on the left) or His10-BiP (on the right). (B) Comparison of the amino acid preferences of MBP-hIRE1a cLD
(blue) and His10-BiP (gray). The peptide arrays were quantified using Max Quant. The binding intensity in each spot was normalized to max signal
intensity in the peptide array. The peptides with the top 10% binding scores were selected and the occurrence of each amino acid in these top-binding
Figure 2 continued on next page
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this point, we compared the binding preferences of mammalian BiP (fused to an N-terminal 10x-histi-
dine tag) on the same peptide arrays. We found sequences recognized by both hIRE1a cLD and BiP
(Figure 2A, Figure 2—figure supplement 1A,B). Importantly, however, we also found profound dif-
ferences. While IRE1 tolerated both prolines and histidines, BiP strongly disfavored these amino
acids (Figure 2B, Figure 2—figure supplement 1A, p<0.05). Conversely, BiP tolerated serine and
threonines, while IRE1 strongly disfavored them. Thus, IRE1 can recognize regions of unfolded pro-
teins to which BiP would not readily bind and vice versa, thereby providing a plausible explanation
of how IRE1 could recognize unfolded proteins despite of the vast excess of BiP over hIRE1a LD in
the ER.
hIRE1a cLD binds peptides with distinct biochemical properties
To measure binding affinities of hIRE1a cLD’s interaction with peptides in solution, we selected the
two peptides with the highest binding scores in the peptide arrays (MPZ- and 8ab-derived peptides,
henceforth referred to as ‘MPZ1’ and ‘8ab1’, respectively) and attached fluorophores at their N-ter-
mini. Fluorescence anisotropy revealed that hIRE1a cLD bound to MPZ1 with K1/2 = 24 ± 4.7 mM and
to 8ab1 with K1/2 = 5 ± 1.7 mM (Figure 2C). (Note that we used K1/2 to denote a measure of affinity
because, as we show below, hIRE1a cLD exists in solution as an ensemble of different interconvert-
ing conformational states and our measurements therefore score several superimposed equilibria.
The measured affinities therefore do not reflect true Kd values). These affinities fall within the same
order of magnitude of chaperone binding to unfolded proteins, supporting the notion that similar
modes of fast transient interactions with unfolded proteins are adopted by both IRE1 and chaper-
ones (Karago¨z et al., 2014; Marcinowski et al., 2011; Street et al., 2011).
To identify the minimal region in MPZ1 for binding to hIRE1a cLD, we next divided MPZ1 into 12,
11 and 9 amino acid long fragments representing its N-terminal (MPZ1-N), middle (MPZ1-M) and
C-terminal (MPZ1-C) regions and measured their respective affinities for hIRE1a cLD. hIRE1a cLD
bound to MPZ1-N with a similar affinity as the full-length peptide (K1/2 = 16.0 ± 2.6 mM, Figure 2D),
whereas the other peptide fragments displayed much lower binding affinities (K1/2 = 377 ± 54 mM
and 572 ± 107 mM, respectively, assuming similar maximum anisotropy values as for the MPZ1-N
peptide). We further truncated MPZ1-N by two residues at a time from either its N- or C-terminus.
Deleting amino acids from the C-terminus gradually decreased the affinity (Figure 2E). By contrast,
deletion of the first two hydrophobic residues from the N-terminus (leucine and isoleucine) abolished
its binding to hIRE1a cLD (Figure 2F). These analyses revealed that the minimum peptide length
with a comparable binding affinity to the full-length MPZ1 peptide is a 12-mer. This 12-mer peptide
matches the chemical properties we found for hIRE1a cLD-binding peptides: it is enriched in
Figure 2 continued
peptides was normalized to their total abundance in the arrays. The normalized occurrences are plotted in log2 scale. Blue stars depict the amino acids
that are significantly enriched or depleted in hIRE1a cLD binders (p<0.05), whereas red stars depict differences in binding preferences of hIRE1a cLD
and BiP (p<0.05). (C) hIRE1a cLD binds peptides derived from proteins MPZ, ‘MPZ1’ (in blue) (peptides F16-F17 in Figure 1a, sequence:
LIRYCWLRRQAALQRRISAME) and 8ab, ‘8ab1’ (in green) (peptide H20 in Figure 1a, sequence: WLCALGKVLPFHRWHTMV) with a K1/2 of 24 ± 4.7 mM
and 5 ± 1.7 mM, respectively, determined by fluorescence anisotropy measurements. (D) Fluorescence anisotropy measurements show that N-terminal
12mer derivative of MPZ1 peptide, ‘MPZ1-N’ binds to hIRE1a cLD with a similar affinity as the full-length peptide, with a K1/2= 16.0 ± 2.6 mM. The
binding curves of N-terminal (MPZ1-N, sequence: LIRYCWLRRQAA), Middle (MPZ1-M, sequence: WLRRQAALQRR) and C-terminal (MPZ1-C, sequence:
LQRRISAME) fragments are shown in black, dark gray, and light gray, respectively. (E) The binding affinity of C-terminal truncations of MPZ1-N for
hIRE1a cLD was measured by fluorescence anisotropy. The binding curves for the truncated peptides are shown in different shades of gray. (F)
Fluorescence anisotropy measurements with N-terminal truncations of the MPZ1-N peptide are shown in different shades of gray. (G) IRE1 cLD binds to
unfolded CH1 domain of IgG1 with a K1/2 of 29.2 ± 1.2 mM determined by microscale thermophoresis measurements. (H) Fluorescence anisotropy
measurements show that MPZ1-N-2X peptide where MPZ1-N peptide sequence is repeated twice in the peptide binds tighter to hIRE1a cLD (peptide
sequence: LIRYAWLRRQAALQRRLIRYAWLRRQAA).
DOI: https://doi.org/10.7554/eLife.30700.005
The following figure supplements are available for figure 2:
Figure supplement 1. hIRE1a cLD shows preference for arginines and aromatic residues.
DOI: https://doi.org/10.7554/eLife.30700.006
Figure supplement 2. hIRE1a cLD binds unfolded proteins.
DOI: https://doi.org/10.7554/eLife.30700.007
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aromatics, hydrophobic amino acids and arginines, indicating that specific binding contacts play a
role in hIRE1a cLD’s interaction with unfolded proteins.
hIRE1a cLD binds unfolded proteins
To validate that peptides are valid surrogates for unfolded proteins, we next tested binding of intact
but constitutively unfolded proteins to hIRE1a cLD. Immunoglobulins (IgGs) mature in the ER using a
well-characterized folding pathway, wherein the constant region domain of the IgG heavy chain
(CH1) remains disordered until it binds to its cognate partner, the constant region domain of the IgG
light chain CL (Feige et al., 2009). We measured the binding affinity of CH1 to hIRE1a cLD by ther-
mophoresis, which reports on changes in the hydration shell of a biomolecule upon interaction with
a partner in solution (Jerabek-Willemsen et al., 2011). By contrast to earlier findings that showed
no measurable binding of hIRE1a cLD to CH1 under different experimental conditions
(Carrara et al., 2015), our experiments showed that hIRE1a cLD interacts with CH1 with a K1/2 =
29.2 ± 1.2 mM (Figure 2G). To further validate this observation, we measured binding of hIRE1a cLD
to another model unfolded protein by fluorescence anisotropy, the folding mutant of staphylococcal
nuclease D131D (Street et al., 2011). We observed a comparable binding affinity of K1/2 = 21.4 ±
2.3 mM (Figure 2—figure supplement 2). Our data thus show that hIRE1a cLD binds to full-length
unfolded proteins with similar affinity as peptides, suggesting that these proteins display a distinct
single binding site for hIRE1a cLD.
To test whether multiple binding sites would increase the affinity for hIRE1a cLD, we synthesized
a peptide consisting of two MPZ1-N tandem repeats separated by a 5-amino acid spacer (MPZ1-N-
2X). Intriguingly, MPZ1-N-2X bound to hIRE1a cLD with an order of magnitude higher affinity (K1/2 =
0.456 ± 0.07 mM) compared to MPZ1 peptide (Figure 2H). As we show below, the increased appar-
ent affinity is due to avidity of hIRE1a cLD to the peptide.
hIRE1a cLD is structurally dynamic
To capture evidence for structural rearrangements in hIRE1a cLD predicted by a switch-mechanism
that oscillates between inactive closed and active open conformations as we suggest in the Introduc-
tion, we employed nuclear magnetic resonance (NMR) spectroscopy. NMR spectroscopy reveals
structural information at the atomic level for dynamic protein complexes and is well suited to study
structural changes in hIRE1a cLD upon its interaction with peptides and unfolded proteins. The
hIRE1a cLD dimer is ~80 kDa and thus is well above the size limit for conventional NMR approaches.
We therefore used methyl transverse relaxation optimized spectroscopy (methyl-TROSY), a specific
NMR method that allows to extract structural information from large proteins after selective isotopic
labeling of side chain methyl groups with carbon-13 (13C) (Tugarinov et al., 2004; Tugarinov et al.,
2007) in select amino acids including isoleucines. hIRE1a cLD has 12 isoleucines per monomer,
which are evenly distributed throughout the protein (Figure 3A). In hIRE1a cLD’s methyl-TROSY
spectra, we resolved seven peaks corresponding to isoleucines (Figure 3B), which then served as
sensors of peptide binding and accompanying conformational changes. All isoleucine peaks in
hIRE1a cLD’s NMR spectrum displayed broad line widths (Figure 3B), which is indicative of chemical
exchange resulting from hIRE1a cLD sampling multiple conformational states at the conditions of
the NMR experiments. These data revealed that hIRE1a cLD is dynamic in solution.
To assign the resolved peaks to specific amino acids in the hIRE1a cLD sequence, we mutated
each isoleucine to leucine, alanine or valine and monitored the disappearance of each resolved peak
in methyl-TROSY spectra of the mutant proteins. This approach allowed us to assign six isoleucine
peaks unambiguously (Figure 3C,D, Figure 3—figure supplements 1, 2 and 3). To further increase
the number of NMR visible probes in hIRE1a cLD, we mutated Leu186 and Thr159 to isoleucines
(Figure 3E,F, Figure 3—figure supplement 1C and F). Leu186 lies in an amphipathic unstructured
loop surrounding the putative groove in hIRE1a cLD. The Leu186Ile peak displayed high signal inten-
sity consistent with a dynamic and flexible position (Figure 3F, Figure 3—figure supplement 1F).
By contrast, Thr159 lies at the b-sheet floor in hIRE1a cLD structure where its side chain faces
towards the MHC-like groove and, as expected, the Thr159Ile substitution resulted in a low-intensity
peak (Figure 3—figure supplement 1C).
We further enhanced the coverage of hIRE1a cLD with NMR-visible probes in complementary
experiments in which we labeled threonine side chains with 13C at their g2 methyl groups (Figure 3—
Karago¨z et al. eLife 2017;6:e30700. DOI: https://doi.org/10.7554/eLife.30700 7 of 29
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Figure 3. NMR spectroscopy reveals dynamic nature of hIRE1a cLD (A) Isoleucines serving as probes in the NMR experiments are evenly distributed
throughout hIRE1a cLD. hIRE1a cLD structural model is shown in gray, with space-filling isoleucine side chains shown in red. The structural model of
hIRE1a cLD was generated by I-Tasser webserver using hIRE1a cLD crystal structure (pdb:2hz6) as a template to visualize the loops that are not
resolved in the crystal structure (Roy et al., 2010; Zhang, 2008). The dimerization interface IF1L of hIRE1a cLD is depicted with a dashed line. (B)
Methyl-TROSY spectrum of hIRE1a cLD with selective 13C labeling at d1- methyl group of isoleucines resolves seven peaks, indicated by red dots. (C)
Ile128 is highlighted as red spheres on hIRE1a cLD structural model. hIRE1a cLD is shown in gray, with isoleucine side chains are depicted as
grayspace-fillings. (D) Assignment strategy for isoleucines in hIRE1a cLD. The WT hIRE1a cLD spectrum (in black) is overlaid with the spectrum of
Ile128Ala mutant (depicted in red). The signal that disappeared in the mutant spectrum corresponds to Ile128 peak and is depicted with a circle. (E)
The side chain of Leu186 is highlighted as red spheres on hIRE1 a cLD structural model. (F) The WT hIRE1a cLD spectrum (in black) is overlaid with the
spectrum of Leu186Ile mutant (depicted in red). The signal that appeared in the mutant spectrum that corresponds Leu186Ile peak is depicted with a
circle.
DOI: https://doi.org/10.7554/eLife.30700.008
The following figure supplements are available for figure 3:
Figure supplement 1. Assignment strategy of the isoleucines in hIRE1a cLD spectrum.
DOI: https://doi.org/10.7554/eLife.30700.009
Figure supplement 2. Assignment strategy of the isoleucines in hIRE1a cLD spectrum.
Figure 3 continued on next page
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figure supplement 4). There are 33 threonine residues in hIRE1a cLD, 24 of which were detected by
the NMR experiments. While we did not assign threonine peaks in hIRE1a cLD spectrum due to high
spectral crowding, they provided an additional ‘fingerprint’ reporting on peptide binding-induced
changes in hIRE1a cLD.
Peptide binding stabilizes the open conformation of hIRE1a cLD
Next, we used methyl-TROSY experiment to monitor changes in the environment of isoleucines and
threonines in hIRE1a cLD upon peptide binding. A largely overlapping subset of isoleucine and threo-
nine peaks shifted when hIRE1a cLD bound to the peptides MPZ1 or 8ab1, indicating a change in a
localized environment upon peptide binding (Figure 4A,B, Figure 4—figure supplement 1A–C). Yet,
a subset of isoleucine and threonine peaks displayed peptide specific changes. The chemical shifts
displayed by the isoleucine peaks were not very large yet reproducible upon binding of different pep-
tides allowing us to probe peptide induced changes in hIRE1a cLD. By contrast, the threonine peaks
displayed larger chemical shifts, which is expected from their higher solvent exposure rendering them
more sensitive to binding events (Figure 4B, Figure 4—figure supplement 1B and C). Mapping the
chemical shift perturbations of the isoleucine peaks upon peptide binding on the hIRE1a cLD struc-
ture (Figure 4A–E, Figure 4—figure supplement 1B, Figure 4—figure supplement 2) revealed that
the isoleucine resonances that shifted most significantly lie on the floor of the central b-sheet (marked
by Ile124, Ile128, Thr159Ile) (Figure 4D and E). Among these isoleucines, only the side chain of
Thr159Ile faces towards the MHC-like groove. We noted that in comparison to the isoleucines 124
and 128, Thr159Ile peak displayed a larger shift upon peptide binding (Figure 4C and E, Figure 4—
figure supplement 1D). In addition to the central b-sheet floor, the aB helix that lies at the ends of
hIRE1a cLD dimer (marked by Ile263), and the b-sandwich connecting the b-sheet floor to the aB helix
(marked by Ile52) were affected, albeit to a lesser extent. By contrast, the unstructured loop extend-
ing from the MHC-like groove (marked by Ile186) was only slightly affected and the isoleucines posi-
tioned in the flexible region that are not resolved in the crystal structure (marked by Ile326 and Ile334)
did not shift (Figure 4D,E).
Importantly, binding of the unfolded protein CH1 shifted the same peaks in the hIRE1a cLD spec-
tra as the short peptides suggesting peptides and unfolded protein chains interact with hIRE1a cLD
in a similar way (Figure 4F, Figure 4—figure supplement 2). Taken together, these results indicate
that peptide as well as unfolded protein binding populate a distinct conformational state of hRE1a
cLD, consistent with a peptide-induced closed-to-open conformational transition. Moreover, the
results are consistent with a model in which peptide binding induces conformational changes that
propagate from the MHC-like groove via the b-sandwich to affect the regions involved in
oligomerization.
Peptide binding maps to the MHC-like groove in hIRE1a cLD
To map the peptide-binding site in hIRE1a cLD with higher precision, we employed paramagnetic
relaxation enhancement (PRE) experiments (Gaponenko et al., 2000; Gillespie and Shortle, 1997)
using MPZ1 modified with a nitroxide spin label, 3-(2-Iodoacetamido)-PROXYL, at cysteine residue,
Cys5 (Figure 5A,B). The unpaired electron in the spin label broadens (in a range of 1 to 2.5 nm) or
entirely erases (distances <1 nm) NMR signals in its vicinity in a distance dependent manner
(Gottstein et al., 2012). Binding of the spin label attached peptide to hIRE1a cLD would result in a
decrease in the intensity of isoleucine peaks depending on their relative distance to the peptide-
binding site. Therefore, we analyzed the changes in the intensities of all isoleucine signals upon bind-
ing of MPZ1-proxyl peptide to hIRE1a cLD (Figure 5B, Figure 5—figure supplement 1A–C). Bind-
ing of MPZ1-proxyl to hIRE1a cLD erased the otherwise very strong signal of Leu186Ile and
Figure 3 continued
DOI: https://doi.org/10.7554/eLife.30700.010
Figure supplement 3. The assigned isoleucines in wild type hIRE1a cLD are depicted on the spectrum.
DOI: https://doi.org/10.7554/eLife.30700.011
Figure supplement 4. Methyl-TROSY spectrum of hIRE1a cLD with selective 13C labeling at g2 methyl group of threonines resolves 24 residues.
DOI: https://doi.org/10.7554/eLife.30700.012
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Figure 4. Peptide binding induces conformational changes in hIRE1a cLD (A) Close-up of the isoleucine peaks in the methyl-TROSY spectrum of
hIRE1a cLD Leu186Ile alone (black, 50 mM) and of hIRE1a cLD Leu186lle bound to MPZ1 (1:1 molar ratio) (upper panel, blue), or to 8ab1 peptide (lower
panel, green, 1:1 molar ratio) shows that peptide binding shifts select peaks. The shift of each peak is indicated with brackets consistent with the color
code in Figure 4—figure supplement 1B, where yellow color indicates chemical shift perturbation values Dn > 0.005, orange, Dn > 0.010 and red
Dn > 0.020. The identities of isoleucine peaks are indicated on top of each peak. (B) Close-up of the threonine peaks in the methyl-TROSY spectrum of
hIRE1a cLD Leu186Ile alone (black, 50 mM) and of hIRE1a cLD Leu186Ile bound to MPZ1 (1:1 molar ratio) (upper panel, blue), or to 8ab1 peptide (lower
panel, green, 1:1 molar ratio) shows that peptide binding shifts select peaks upon binding of peptides. The chemical shift of each peak is indicated as
in Figure 4A based on the chemical shift perturbations calculated in Figure 4—figure supplement 1C. (C) Close-up of select isoleucine peaks in the
Figure 4 continued on next page
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broadened that of Ile124 (Figure 5B–D and Figure 5—figure supplement 1A–C). Importantly,
Ile128 and Ile263 signals, which shifted upon MPZ1 binding as discussed above (Figure 4E), broad-
ened to a lesser extent, suggesting that these residues lie further from the peptide-binding site (Fig-
ure 5—figure supplement 1C and D). Their resonances therefore shifted due to peptide-induced
distant conformational rearrangements. Displaying the normalized PRE effect on hIRE1a cLD struc-
ture revealed that MPZ1-proxyl binding mapped to the center of the MHC-like groove, suggesting
that peptides bind to MHC-like groove and induce distant conformational changes in hIRE1a cLD
(Figure 5D).
Peptide binding induces oligomerization of hIRE1a cLD
To test whether the distant conformational changes in hIRE1a cLD monitored by the NMR experi-
ments are due to peptide binding-induced oligomerization, we employed analytical ultracentrifuga-
tion (AUC) sedimentation velocity experiments to assess the oligomeric status of hIRE1a cLD in the
absence and presence of peptides. At the concentration range used at NMR experiments (25–75
mM), hIRE1a cLD was found as a mixture of various oligomeric states, where the main peaks corre-
sponded to dimers and tetramers (with higher amount of tetramers formed at higher concentrations,
see Figure 6A). Notably, binding of MPZ1-N to hIRE1a cLD at the NMR concentrations sharpened
the tetramer peak and induced formation of larger oligomeric species in these experiments
(Figure 6A). The peptide concentration used in these experiments does not saturate hIRE1a cLD
molecules based on a determined K1/2 of 16.0 ± 2.6 mM, therefore only a small population of hIRE1a
cLD formed higher oligomers (depicted as the pink area) (Figure 6A).
To assess hIRE1a cLD’s oligomeric status at varying hIRE1a cLD concentrations, we performed
size exclusion chromatography and found that hIRE1a cLD eluted at earlier fractions in a concentra-
tion-dependent manner (Figure 6—figure supplement 1A). AUC data confirmed these findings and
showed that at concentrations close to its dimerization constant of 2.5 mM, hIRE1a cLD sediment as
a single peak with a sedimentation coefficient corresponding to a mixture of monomers and dimers
(Figure 6B, Figure 6—figure supplement 1B). In this concentration regime (from 1 to 2.5 mM), the
hIRE1a cLD peak progressively shifted to higher sedimentation values with increasing hIRE1a cLD
concentration (Figure 6—figure supplement 1B). Peptide binding to hIRE1a cLD shifted the hIRE1a
cLD population to even higher sedimentation values (Figure 6B, blue trace), indicating that under
these conditions peptide binding stabilized hIRE1a cLD dimers and lead to the formation of
oligomers.
Oligomerization leads to global conformational changes in hIRE1a cLD
As hIRE1a cLD populated distinct oligomeric states in a concentration-dependent manner, we next
compared the conformational state of hIRE1a cLD at 5 mM (no higher-order oligomer formation
Figure 4 continued
methyl-TROSY spectrum of hIRE1a cLD T159I mutant alone (black, 25 mM) and in the spectrum of hIRE1a cLD bound to MPZ1-N peptide (1:1 molar
ratio) (blue). The chemical shift of each peak is indicated with brackets consistent with the color code in Figure 4—figure supplement 1B,D. (D)
Important structural regions of hIRE1 cLD are depicted on the structural model of hIRE1a cLD by arrows. The red dashed-lines indicate the dimerization
interface IF1L of hIRE1a cLD, whereas the black box shows the b-sheet floor of the MHC-like groove. (E) The isoleucine peaks shifting upon MPZ1
binding are mapped into the hIRE1a cLD structural model based on their combined chemical shift perturbation values as shown in Figure 4—figure
supplements 4 and 6. The red spheres indicate isoleucine peaks with significant shifts (Dn > 0.020), orange; moderate shifts Dn > 0.010, and yellow
spheres show isoleucines that shift slightly upon peptide binding, Dn > 0.005. The isoleucine peaks that do not change significantly (Dn < 0.005) are
depicted in blue. (F) Close-up of select isoleucine peaks in the methyl-TROSY spectrum of hIRE1a cLD triple mutant Ile326/334/362Leu alone (black, 50
mM) overlaid with the spectrum of hIRE1a cLD when bound to CH1 domain (1:1 molar ratio) (red). The shifts are indicated with brackets consistent with
color coding in Figure 4B and Figure 4—figure supplement 1B,D.
DOI: https://doi.org/10.7554/eLife.30700.013
The following figure supplements are available for figure 4:
Figure supplement 1. Peptide induced conformational changes in hIRE1a cLD.
DOI: https://doi.org/10.7554/eLife.30700.014
Figure supplement 2. Chemical shift perturbation analysis of isoleucine signals upon binding of CH1 domain to hIRE1a cLD I326-334-362L triple mutant
(based on the spectrum in Figure 4f).
DOI: https://doi.org/10.7554/eLife.30700.015
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detected by AUC) to 50 mM (based on Figure 6C, approximately 60% higher-order oligomer forma-
tion) by NMR spectroscopy to probe for the structural differences assumed by these two distinct
states (Figure 6C,D). In these experiments, we relied on the high sensitivity of selective isoleucine
labeling strategy, which could readily detect hIRE1a cLD signals at concentrations as low as 5 mM
(Figure 6—figure supplement 2A,B).
Notably and similar to effects observed upon peptide binding, oligomerization changed the envi-
ronment of the aB helix (marked by Ile263) and the b-sandwich connecting the b-sheet floor to the
aB helix (marked by Ile52) that both lie at the tips of hIRE1a cLD dimers (Figure 6D,E, Figure 6—
figure supplement 2C). These data suggest that these isoleucines are part of the oligomerization
interface and/or that their conformational rearrangements are coupled to the formation of the inter-
face. Moreover, NMR experiments showed chemical shifts in the isoleucines on the beta sheet floor
of the groove (marked by Ile124 and Ile128) upon formation of higher oligomers (Figure 6E). These
coupled, global conformational differences observed by NMR strongly underscore the notion that
oligomeric hIRE1a cLD adopts an active conformation and displays higher affinity for unfolded
Figure 5. Peptide binding maps to the center of MHC-like groove (A) Schematic representation of the spin label attached MPZ1 peptide. (B)
Comparison of the methyl-TROSY spectra of hIRE1a cLD Leu186Ile in the absence (black, 75 mM) and presence of spin-labeled MPZ1 peptide (red, 1:1
molar ratio). (C) The normalized PRE effect on isoleucine peaks upon binding of spin-labeled peptide. The intensity of isoleucine peaks upon MPZ1-
proxyl binding is divided by their intensity in the reference spectrum (IPRE/I0) (Figure 5—figure supplement 1C) and further normalized to their surface
exposed area to exclude possible contributions from non-specific interactions with the spin label attached peptide (Clore and Iwahara, 2009) (see
Materials and methods). (D) The normalized PRE effect is mapped on the structural model of hIRE1a cLD. The isoleucine peaks in hIRE1a cLD that are
broadened upon peptide binding are depicted with a color gradient from red to green as space filling side-chains in the hIRE1a cLD structural model
based on decreasing degree of broadening using normalized PRE effect in Figure 5C.
DOI: https://doi.org/10.7554/eLife.30700.016
The following figure supplement is available for figure 5:
Figure supplement 1. Peptide binding maps to the center of the MHC-like groove in hIRE1a cLD.
DOI: https://doi.org/10.7554/eLife.30700.017
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Figure 6. hIRE1a cLD forms dynamic oligomers (A) AUC sedimentation velocity measurements of hIRE1a cLD alone (75 mM) (gray line) versus hIRE1a
cLD with 75 mM MPZ1-N peptide (blue line). Pink region indicates larger hIRE1a cLD oligomers formed upon peptide binding. (B) AUC sedimentation
velocity measurements of hIRE1a cLD alone (5 mM) (gray line) versus hIRE1a cLD with 50 mM MPZ1 peptide (blue line), pink region indicates the shift in
the AUC profile upon peptide binding. (C) AUC sedimentation velocity measurements of hIRE1a cLD at 5, 25 and 75 mM are shown in different shades
of gray. (D) Close-up of isoleucine peaks in the methyl-TROSY spectrum of hIRE1a cLD at 5 mM (black) overlaid with the spectrum of hIRE1a cLD at 50
mM (red). (E) The isoleucine peaks shifting upon oligomerization are mapped into the hIRE1a cLD structure based on the chemical shift perturbation
values shown in Figure 6—figure supplement 2C. The red spheres indicate isoleucine peaks that display most significant shifts (Dn > 0.020), orange;
moderate shifts Dn > 0.010, and yellow; slight shifts Dn > 0.005. The isoleucine peaks that do not change significantly (Dn < 0.005) are depicted in blue.
DOI: https://doi.org/10.7554/eLife.30700.018
The following figure supplements are available for figure 6:
Figure supplement 1. hIRE1a cLD forms oligomers.
DOI: https://doi.org/10.7554/eLife.30700.019
Figure supplement 2. Oligomerization leads to global conformational changes in hIRE1a cLD.
DOI: https://doi.org/10.7554/eLife.30700.020
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protein ligands. To address this notion, we set out to experimentally determine the oligomerization
interface and then impair the oligomerization of hIRE1a cLD by mutation.
Identifying the oligomerization interface of hIRE1a cLD
We employed a chemical cross-linking strategy coupled to mass spectrometry to experimentally
determine residues that map to the oligomerization interface in hIRE1a cLD. To this end, we cross-
linked hIRE1a cLD in the presence and absence of peptides by a homobifunctional cross-linker, BS3
(bis(sulfosuccinimidyl)suberate), which crosslinks primary amines mainly present in lysine side chains.
Denaturing SDS-PAGE analysis of hIRE1a cLD after cross-linking revealed that cross-linking captured
oligomeric hIRE1a cLD (Figure 7A, Figure 7—figure supplement 1). We separately isolated the
bands corresponding to hIRE1a cLD monomers, dimers and higher oligomers from the gel and ana-
lyzed peptides by mass spectrometry. We identified cross-linked peptides by accurate mass mea-
surement of both candidate peptides and their fragment ions (Chu et al., 2010; Trnka et al., 2014).
In comparative analyses, we separated intra- from inter-molecular cross-links by focusing on peaks
that were present only in the covalent dimers and higher oligomers (Wu et al., 2013; Zeng-
Elmore et al., 2014). These analyses revealed five abundant cross-links between lysines 120.120,
53.347, 53.349, 53.351 and 265.351 (Figure 7A, Table 1).
Previous studies of BS3-cross-linked proteins with known crystal structures established that the
distance between the aC atoms of cross-linked lysines is less than 28 A˚ for most cross-links but can
be up to 33 A˚ for a few cases due to local protein flexibility (Leitner et al., 2010), in agreement with
the additive lengths of the cross-linker itself plus twice the length of the lysine side chain. The
Lys120.120 cross-link maps to hIRE1a cLD’s dimerization interface (IF1L), whereas the four other
cross-links are compatible with being positioned at hIRE1a cLD oligomerization interface, IF2L. The
cross-links Lys53.347, Lys53.349, Lys53.351 and Lys265.351 each involve one lysine residue (Lys53
and Lys263) that is close to the isoleucines (Ile52 and Ile263) that shifted upon hIRE1a cLD oligomer-
ization (Figure 6D,E), suggesting that they report on the formation of hIRE1a cLD’s putative oligo-
merization interface IF2L. Lys347, Lys349 and Lys351 are located in a region that was not resolved in
hIRE1a cLD crystal structure, suggesting that these regions are contributing to the formation of the
oligomerization interface in hIRE1a cLD.
We next threaded the sequence of hIRE1a cLD into the yeast crystal structure of the oligomeric
state, which fulfilled the distance restraints imposed by the cross-links (Figure 7B,C). This structural
model predicted an extensive interface formed by hIRE1a cLD oligomers that involves residues from
parts of hIRE1 cLD that are not resolved in the crystal structure, as well as the incomplete b-propeller
involved in the formation of the oligomerization interface in yeast Ire1 cLD (Figure 7C).
We used the predictive power of the structural model (hIRE1 cLD threaded into the yeast struc-
ture) to identify a patch of four hydrophobic residues WLLI (aa 359–362) suggested to contribute to
the hIRE1a cLD oligomerization interface IF2L (Figure 7C, Figure 7—figure supplement 2). Assum-
ing that these residues would be critical for oligomerization, we mutated them (WLLI359-362 to
GSGS359-362; ‘IF2L mutant’) and assessed whether the hIRE1a cLD IF2L mutant formed oligomers by
AUC sedimentation velocity analysis. The experiments revealed that, at a concentration (50 mM)
where wild type hIRE1a cLD readily forms oligomers, the hIRE1a cLD IF2L mutant sediment as a sin-
gle dimeric peak, showing that the mutation prevents hIRE1a cLD oligomerization (Figure 7D).
The peptide-induced allosteric switch remains intact in hIRE1a cLD IF2L
mutant
To assess whether hIRE1a cLD IF2L mutant is functional, we tested peptide binding by fluorescent
anisotropy experiments. The IF2L mutant bound MPZ1-N and MPZ1-N-2X peptide at similar affinities
to the wild type protein (with K1/2 = 5.4 ± 1.4 mM and K1/2 = 0.95 ± 0.4 mM, respectively) (Figure 7E,
Figure 7—figure supplement 3A). These results indicated that hIRE1a cLD dimer is the functional
unit for peptide binding and that hIRE1a cLD oligomers do not display a higher affinity conforma-
tion. Moreover, they also showed that the avidity effect that resulted in higher affinity binding of
MPZ1-N-2X peptide to hIRE1a cLD does not require formation of higher hIRE1a cLD oligomers.
AUC data confirmed these analyses and showed that binding of MPZ1-N-2X to hIRE1a cLD
IF2Lmutant stabilized dimer formation but did not lead to formation of oligomers bridged by MPZ1-
N-2X peptide (Figure 7E, Figure 7—figure supplement 3B and C).
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Figure 7. Cross-linking coupled to mass spectrometry identified the oligomerization interface of hIRE1a cLD (A) Tandem mass spectrometry (MS)
profile of the peptide crosslinked at Lys53 and Lys351. Extracted Ion chromatography (XIC) of the peptide peak in monomeric versus oligomeric hIRE1a
Figure 7 continued on next page
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The hIRE1a cLD IF2L mutant therefore enabled us to decouple peptide induced allosteric commu-
nication from the formation of oligomers, both of which could have contributed to the shift of the
isoleucine peaks in the NMR experiments. To address this notion, we repeated the NMR experi-
ments with the IF2L mutant (Figure 7F, Figure 7—figure supplement 4A–C). Similar to WT hIRE1a
cLD, MPZ1-N peptide binding to hIRE1a cLD IF2L mutant shifted isoleucines in the b-sheet floor
(marked by Ile124 and Ile128) (Figure 7F and G, Figure 7—figure supplement 4B and C). Impor-
tantly, isoleucine peaks (Ile52 and Ile263) close to the oligomerization interfaces also shifted upon
peptide binding to the hIRE1a cLD IF2L mutant. Thus peptide binding-induced conformational
changes in isoleucines distant to the peptide binding site persisted in the hIRE1a cLD IF2L mutant.
Interestingly, MPZ1-N-2X binding shifted isoleucine peaks in the same direction and to a similar
extent as binding of MPZ1-N, indicating that hIRE1a cLD IF2L binds to the same site in these
Figure 7 continued
cLD shows its absence in cross-linker treated monomer proteins. (B) Mapping cross-link sites on the structural model of hIRE1a cLD by threading on the
oligomeric yeast crystal structure. Each monomer is colored as shades of gray. The Lys53, Lys265 are shown as orange and blue spheres, respectively,
and Lys347,Lys349, Lys351 are shown as red spheres. The dashed lines indicate the cross-links between the lysines. (C) The amino acids forming the
oligomerization interface are shown as spheres and colored by red (indicating oxygens), blue (indicating nitrogens) and white (indicating carbons). The
Trp359 that is mutated in the hIRE1a cLD IF2L mutant is colored as green and pink in different protomers. (D) 359WLLI362-GSGS mutation (hIRE1a cLD
IF2L mutant) impairs hIRE1a cLD oligomerization determined by AUC sedimentation velocity experiments. Gray line depicts wild type hIRE1 a cLD (25
mM) and red shows the hIRE1a cLD IF2L mutant (50 mM). (E) hIRE1a cLD IF2L mutant binds MPZ1-N-2X peptide (red curve) at similar affinity K 1/2=0.95 ±
0.4 as wild type hIRE1a cLD (black curve)(K1/2 = 0.456 ± 0.7 mM) determined by fluorescence anisotropy measurements. (F) Close-up of isoleucine peaks
in the methyl-TROSY spectrum of hIRE1a cLD IF2L mutant alone (black, 50 mM) overlaid with the spectrum of hIRE1a cLD bound to MPZ1-N-2X (upper
panel, red, 1:1 molar ratio). (G) The isoleucine peaks shifting upon peptide binding to hIRE1a cLD IF2L mutant are mapped on hIRE1a cLD structural
model based on the chemical shift perturbations calculated in Figure 7—figure supplement 4) consistent with the color code in Figure 4E.
DOI: https://doi.org/10.7554/eLife.30700.021
The following figure supplements are available for figure 7:
Figure supplement 1. SDS-PAGE analysis of BS3 (1 mM) cross-linked hIRE1a cLD (20 mM).
DOI: https://doi.org/10.7554/eLife.30700.022
Figure supplement 2. The hydrophobic stretch 359WLLI362 that is mutated in hIRE1a cLD IF2L mutant is shown on the structural model of hIRE1a cLD
based on yeast crystal structure.
DOI: https://doi.org/10.7554/eLife.30700.023
Figure supplement 3. hIRE1a cLD IF2L mutant binds peptides.
DOI: https://doi.org/10.7554/eLife.30700.024
Figure supplement 4. Peptide induced allosteric coupling is intact in hIRE1a cLD IF2L mutant.
DOI: https://doi.org/10.7554/eLife.30700.025
Table 1. List of cross-linked peptides in hIRE1a cLD detected by mass spectrometry and their relative abundance.
Band number on the SDS-PAGE (with peptides) Band number on the SDS-PAGE (without peptides)
Xlink 1 Xlink 2 5 4 3 2 1 (monomer) Xlink 1 Xlink 2 5 4 3 2 1 (monomer)
K53 K347 AVE (%) 4.1% 3.2% 3.7% 4.9% 0.0% K53 K347 AVE (%) 3.3% 4.3% 4.4% 3.4% 0.0%
STDEV(%) 0.4% 1.9% 1.0% 1.0% 0.0% STDEV(%) 0.3% 1.9% 2.1% 2.5% 0.0%
K53 K349 AVE (%) 1.4% 1.0% 1.4% 1.5% 0.0% K53 K349 AVE (%) 1.6% 1.4% 1.6% 1.6% 0.0%
STDEV(%) 0.2% 0.4% 0.3% 0.8% 0.0% STDEV(%) 0.5% 0.5% 0.9% 0.5% 0.0%
K53 K351 AVE (%) 4.0% 2.4% 3.2% 3.4% 0.0% K53 K351 AVE (%) 2.3% 3.2% 2.6% 2.1% 0.0%
STDEV(%) 1.1% 2.4% 0.8% 0.3% 0.0% STDEV(%) 0.4% 1.0% 1.7% 2.3% 0.0%
K121 K121 AVE (%) 3.7% 2.9% 1.5% 0.8% 0.0% K121 K121 AVE (%) 2.6% 2.1% 2.1% 0.3% 0.0%
STDEV(%) 0.9% 1.4% 0.0% 0.3% 0.0% STDEV(%) 0.2% 0.8% 1.5% 0.1% 0.0%
K351 K265 AVE (%) 1.2% 0.8% 1.0% 0.4% 0.0% K351 K265 AVE (%) 0.6% 0.9% 0.9% 0.4% 0.0%
STDEV(%) 0.1% 0.6% 0.5% 0.3% 0.0% STDEV(%) 0.3% 0.2% 0.4% 0.3% 0.0%
K53 K265 AVE (%) 0.5% 0.4% 0.2% 0.2% 0.0% K53 K265 AVE (%) 0.3% 0.4% 0.3% 0.1% 0.0%
STDEV(%) 0.1% 0.1% 0.0% 0.0% 0.0% STDEV(%) 0.1% 0.3% 0.1% 0.1% 0.0%
DOI: https://doi.org/10.7554/eLife.30700.026
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peptides (Figure 7G, Figure 7—figure supplement 4B and C). These data suggest that the
increased affinity of MPZ1-N-2X is due to a decreased rate of dissociation of the peptide.
IRE1 lumenal domain-driven oligomerization is crucial for IRE1 function
in mammalian cells
To test the importance of lumenal domain driven oligomerization for hIRE1a function in vivo, we
generated cell lines that stably express hIRE1a IF2L mutant as the only form of hIRE1a. To this end,
we introduced the hIRE1a IF2L mutant into mouse embryonic fibroblasts (MEFs) deficient for both
isoforms of IRE1 (IRE1a / /IRE1b / ). In addition, we attached a GFP tag to IRE1’s cytoplasmic flexi-
ble linker retaining its function as published previously for HEK293 cells (Li et al., 2010). In parallel,
we introduced hIRE1a-GFP to IRE1a / /IRE1b /  MEFs to compare hIRE1a activity at similar condi-
tions. In these cell lines, we controlled hIRE1a expression via a doxycycline-inducible promoter. In
the absence of doxycycline, cells expressed low levels of hIRE1a due to the leakiness of the pro-
moter. In those conditions, the expression level of the hIRE1a-GFP-IF2L mutant was similar to
hIRE1a-GFP and to the level of endogenous IRE1a from wild-type MEFs, as assessed by Western
blot analysis (Figure 8A,B).
We next monitored the XBP1 mRNA splicing activity of IRE1 in IRE1a / /IRE1b /  MEFs harbor-
ing hIRE1a-GFP or hIRE1a-GFP-IF2L mutant (Figure 8C). We found that unlike hIRE1a-GFP, hIRE1a-
GFP-IF2L mutant did not splice XBP1 mRNA after induction of ER stress by tunicamycin, a chemical
stressor that impairs ER-folding homeostasis by inhibiting N-linked glycosylation
(Figure 8C, Figure 8—figure supplement 1) (Heifetz et al., 1979). IRE1’s RNase activity is pre-
ceded by the autophosphorylation of its kinase domain, which can be monitored by a phospho-spe-
cific antibody. Western blot analysis showed no signal corresponding to phospho-IRE1 in the
IRE1a / /IRE1b /  cells expressing hIRE1a–GFP-IF2L, by contrast to the same cells reconstituted
with wild type hIRE1a-GFP, or in contrast to wild type MEFs, in which we detected phosphorylation
of the endogenous protein (Figure 8B, Figure 8—figure supplement 2). Lastly, confocal microscopy
revealed that under ER stress conditions where hIRE1a-GFP readily formed foci (>70%, n = 88,
Figure 8D, Figure 8—figure supplement 3A), reflecting its assembly into active oligomers, the
hIRE1a-GFP-IF2L mutant failed to do so (Figure 8D, Figure 8—figure supplement 3B and C). These
data confirmed that cLD-mediated oligomerization is crucial for IRE1 function in cells.
Discussion
To date, the mechanism by which mammalian IRE1 senses ER stress has remained controversial.
Here, we provide evidence that activation of human IRE1a occurs via direct recognition of unfolded
proteins and that the mechanism of ER stress sensing is conserved from yeast to mammals. This con-
clusion is based on six independent lines of evidence. First, we found that hIRE1a cLD binds pepti-
des with a characteristic amino acid bias. Second, NMR spectroscopy suggested that peptides bind
to hIRE1a cLD’s MHC-like groove and induce a conformational change including the distant aB
helix. In this way, occupation of the peptide-binding groove is allosterically communicated, which,
we propose, culminates in the formation of a functional oligomerization interface corresponding to
IF2L in yIRE1 cLD. Third, binding of minimal-length peptides induces formation of hIRE1a cLD
oligomers as assessed by AUC analyses, further supporting this notion. Fourth, cross-linking experi-
ments captured the oligomerization interfaces, which allowed identification of a functionally crucial
hydrophobic patch at IF2L. Fifth, mutation of this patch uncoupled peptide binding from oligomeri-
zation but retained the allosteric coupling within the domain. Sixth, impairing the oligomerization of
hIRE1a cLD abolished IRE1’s activity in living cells, attesting to the physiological relevance of the
activation mechanism proposed here.
Taken together, our data converge on a model (Figure 9) in which unfolded protein-binding acti-
vates a switch in hIRE1a’s cLD, leading to rearrangements that render it compatible with the forma-
tion of IF2L and therefore stabilizing an active oligomeric conformation (Video 1). cLD-mediated
oligomerization on the lumenal side of the ER, in turn, would juxtapose hIRE1a’s cytosolic kinase
domains in the face-to-face confirmation allowing its trans-autophosphorylation, followed by stack-
ing of its RNase domains in back-to-back orientation. These conformational rearrangements then
lead to RNase activation, and thus allowing information flow across the ER membrane. Interestingly,
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our data show that impairment of lumenal domain oligomerization diminished IRE1’s both RNase
and kinase activities in cells.
Currently due to lack of biochemical and structural understanding of IRE1’s interaction with the
ER-resident chaperone BiP, its role in regulating IRE1 activity remains unknown. Although it is clear
that BiP is released from IRE1 upon ER stress (Bertolotti et al., 2000), current models proposing BiP
as the primary regulator of IRE1 activity do not address how active IRE1 oligomers would form
(Carrara et al., 2015; Oikawa et al., 2009; Zhou et al., 2006). By contrast, our data indicate that
Figure 8. Lumenal domain driven oligomerization is crucial for IRE1 function (A) Western blot analyses show the levels of hIRE1a-GFP and hIRE1a-
GFP-IF2L mutant proteins stably expressed in IRE1a / /IRE1b /  MEFs in response to various doxycycline concentrations. hIRE1a is detected by anti-
IRE1 antibody and GAPDH is probed as the loading control. The lower panel shows Western blot analysis comparing IRE1 levels in hIRE1a-GFP and
hIRE1a-GFP-IF2L mutant cell lines in the absence of doxycycline side by side. (B) Western blot analyses of hIRE1a-GFP and hIRE1a-GFP-IF2L mutant
reconstituted in IRE1a / /IRE1b /  MEFs and MEFs isolated from wild type mice are probed with anti-IRE1 and anti-phospho-IRE1 antibody. The cells
are treated with 5 mg/ml tunicamycin for inducing ER stress. (C) Unlike hIRE1a-GFP, the hIRE1a-GFP-IF2L mutant does not splice XBP1 mRNA after
induction of ER stress by the chemical ER stressor tunicamycin (5 mg/ml). XBP1 mRNA splicing is determined by semi quantitative PCR. The spliced and
unspliced forms of XBP1 mRNA are indicated. Splicing assays in are conducted in IRE1a / /IRE1b /  MEFs reconstituted with hIRE1a-GFP or the
hIRE1a-GFP-IF2L mutant in the absence of doxycycline. (D) Confocal microscopy images of IRE1a / /IRE1b /  MEFs reconstituted with hIRE1a-GFP-
IF2L mutant and hIRE1a-GFP after 4 hr of chemically induced ER stress by tunicamycin (5 mg/ml).
DOI: https://doi.org/10.7554/eLife.30700.027
The following figure supplements are available for figure 8:
Figure supplement 1. Unlike hIRE1a-GFP, the hIRE1a-GFP-IF2L mutant does not splice XBP1 mRNA after induction of ER stress by tunicamycin
(Tm, 5 mg/ml) at various time points and 2 hr after thapsigargin (Tg, 100 nM) treatment.
DOI: https://doi.org/10.7554/eLife.30700.028
Figure supplement 2. Western blot analyses of cell lysates collected at various times after ER stress induction from IRE1a / /IRE1b /  MEFs
reconstituted with hIRE1a-GFP and hIRE1a-GFP-IF2L (‘L’ for lumenal) mutant are probed with anti-phospho IRE1 antibody (upper panel), whereas
GAPDH is the loading control (lower panel).
DOI: https://doi.org/10.7554/eLife.30700.029
Figure supplement 3. hIRE1a-GFP-IF2L mutant does not form foci.
DOI: https://doi.org/10.7554/eLife.30700.030
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peptide-binding is important for lumenal domain-driven IRE1 oligomerization, leading to its activa-
tion. We therefore consider it most plausible that BiP binding modulates the response via tuning
IRE1’s oligomerization equilibrium, similar to what was shown for the yeast counterpart
(Pincus et al., 2010). In this way, BiP binding would buffer IRE1 activity at the early stages of the ER
stress when the chaperones are not overwhelmed by the unfolded protein load, and during the
deactivation phase, when the protein folding homeostasis is achieved. In this scenario, unfolded pro-
tein accumulation exerts synergistic effects on IRE1 activation, simultaneously freeing more IRE1
from BiP upon ER stress and inducing IRE1’s oligomerization/activation through their direct binding
to the sensor (Pincus et al., 2010).
Despite these profound similarities in the salient features of ER stress sensing and processing,
yeast and human IRE1a cLD display some distinct oligomerization properties. Whereas yIRE1 cLD
precipitously assembles into larger oligomers at concentrations that exceed its dimerization constant
(Gardner and Walter, 2011), hIRE1a cLD forms discrete dimers, which in a concentration-depen-
dent manner gradually assemble into tetramers. hIRE1a cLD oligomers are in a dynamic equilibrium
of different states, apparent from our size exclusion chromatography and AUC analyses and hIRE1a
cLD forms even larger oligomers when bound to peptides. These observations are consistent with
the model that the aB helix, which may hinder formation of hIRE1a oligomers as previously sug-
gested (Zhou et al., 2006) participates in conformational changes that release its block on oligomer-
ization. At higher hIRE1a cLD concentrations, the conformational equilibrium of the aB helix is
Step 2
Step 3
Step 4
Step 1
IRE1 activation
Figure 9. Model of human IRE1 activation Apo-hIRE1a LD dimers are found in equilibrium between closed and open conformations (Step 1) (note that
for simplicity IRE1’s cytoplasmic kinase/RNase domains are not displayed in the model). Upon ER stress, unfolded proteins accumulating in the ER
lumen bind hIRE1a LD. Unfolded protein binding stabilizes hIRE1a LD in the open conformation and induces a conformational change in the aB helix
and the neighboring structural elements (Steps 2). This conformational change releases the block on oligomerization, thus leading to active hIRE1a
oligomers by allowing the formation of an IF2L-like interface in hIRE1a LD (Step 3). Oligomerization driven by hIRE1a LD subsequently activates its
kinase and RNase domains. When protein-folding homeostasis is achieved, the dynamic hIRE1a LD oligomers re-adopt the inactive hIRE1a LD
conformation (Step 4).
DOI: https://doi.org/10.7554/eLife.30700.031
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shifted towards the active state. Peptide binding allosterically releases this inhibition and stabilizes
the active hIRE1a oligomers. We anticipate that the effect of peptide binding-induced oligomeriza-
tion would be more pronounced under physiological conditions, where hIRE1a is tethered to ER-
membrane with diffusion limited to two dimensions.
We speculate that the conformational change in the aB helix allows the incomplete b-propeller to
form contacts with the residues from the flexible region, which is not resolved in the crystal structure
(V307-Y358) forming the oligomerization interface in hIRE1a cLD. In this conformation, aB helix may
provide additional contact sites contributing to the oligomerization interface. Interestingly, one of
the symmetry mates captured by hIRE1a cLD crystal structure shows contacts of the aB helix with
the hydrophobic stretch (359WLLI362), which we show to be important for oligomerization. We antici-
pate that in addition to this hydrophobic stretch, additional contacts contributed by these flexible
parts may further facilitate oligomer formation.
hIRE1a cLD’s groove is enriched in aromatic residues and displays a negatively charged surface.
In this way, the amino acids lining the groove chemically complement hIRE1a cLD binding peptides
identified in our study, which are enriched in aromatics and arginines. In the crystal structure of
hIRE1a cLD in the ‘closed’ conformation, the a-helices forming the MHC-like groove are close
together and mask the residues on the b-sheet floor. When these helices are moved approximately
6 A˚ apart from one another, the groove deepens and exposes more hydrophobicity mostly contrib-
uted by newly exposed aromatic residues. Thus, opening the groove exposes surface chemistry that
is conducive to IRE1 binding peptides. Our data support a model in which widening of the groove is
allosterically coupled to the formation of the IF2L-like oligomerization interfaces.
We showed that a 12-mer peptide is the shortest derivative of MPZ1 peptide that binds hIRE1a
cLD with undiminished affinity when compared to the original 21-mer peptide, indicating that a 12-
mer provides maximal contact with cognate interfaces in hIRE1a cLD groove. It is plausible that simi-
lar to MHC molecules, select amino acids in unfolded polypeptides act as ‘anchor residues’ provid-
ing contact sites for hIRE1 a cLD binding (Fremont et al., 1992; Matsumura et al., 1992;
Wilson and Fremont, 1993). Notably, assuming an extended peptide backbone with an average
length of 3.4 A˚ per peptide bond, a 12-mer peptide can fit without constraints into the 39 A˚-long
groove in the structural model presented here. This notion suggests that the groove ensures prefer-
ential binding of fully exposed, unfolded 39A˚-stretch of a polypeptide chain. This recognition princi-
ple is therefore similar to that of Hsp70-type chaperones, where the structural constraints in the
cavity of the substrate-binding domain allow interaction with the substrates only in their extended,
unfolded conformation, although Hsp70 only binds a seven amino acids stretch (Ru¨diger et al.,
1997a; Ru¨diger et al., 1997b).
Supporting the notion of mechanistic similarities in unfolded protein recognition between chaper-
one proteins and IRE1, hIRE1a cLD and the ER-resident chaperone BiP bind partially overlapping as
well as distinct sets of peptides tested in our peptide arrays, as previously shown for the orthologous
yeast proteins (Gardner and Walter, 2011). Importantly, the presence of distinct hIRE1a cLD bind-
ing peptides liberates IRE1 from an otherwise inevitable failure to compete with highly abundant BiP
for binding sites in unfolded proteins. hIRE1a cLD’s affinity for peptides measured here varied
between 5 and 30 mM, which is within the same order of magnitude but at the lower range of those
reported for most chaperones (Karago¨z et al., 2014; Marcinowski et al., 2011; Street et al.,
2011). For example, hIRE1a cLD binds the IgG’s CH1 unfolded domain with ~30 mM affinity whereas
BiP was shown to bind the same protein with ~7 mM (Marcinowski et al., 2011). We surmise that
this difference has been selected in evolution to set the threshold for unfolded protein recognition
slightly higher for the UPR sensors when compared to that of chaperones so that the UPR is not trig-
gered until a critical concentration of unfolded proteins accumulates. Moreover, our data with the
MPZ1-N-2X peptide suggested that IRE1 could display higher affinity for select polypeptides that
present more than a single IRE1 binding site.
IRE1 dysfunction contributes to the development of numerous diseases, including cancer (such as
multiple myeloma [Mimura et al., 2012]), metabolic disorders (such as obesity and diabetes
[Fonseca et al., 2009; Hotamisligil, 2010]) and neurodegenerative diseases (such as amyotrophic
lateral sclerosis and Hungtinton’s disease [Hetz et al., 2009; Matus et al., 2009; Vidal et al.,
2012]). Depending on the disease context, IRE1 makes life or death decisions in response to altered
ER function manifested in these pathological conditions (Walter P. and D., 2011). Our data showing
that unfolded proteins stabilize a distinct IRE1 conformation suggest novel approaches to
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manipulate IRE1 pharmacologically. For example, it will be promising to design or screen for small
molecule modulators that lock IRE1’s groove in the open or closed conformation based on the
chemical signature of the IRE1 binding peptides identified here. Such compounds could act as ago-
nists or antagonists of IRE1 activity. As such, it should be possible to develop new classes of pharma-
ceuticals to induce or inhibit the IRE1 branch of the UPR, driving the desired IRE1 output depending
on the disease context.
Materials and methods
Reagents
Synthetic peptides were ordered from Elim Biosciences and GenScript at >95% purity.
Protein purification
To express MBP-hIRE1a cLD (aa 24–389), human IRE1a cDNA sequences were cloned into a
pMalC2p vector to create a hIRE1a cLD fused on its N-terminus to MBP. To express His10-hIRE1a
cLD, hIRE1a cLD was cloned into pet16b(+) vector containing a FactorXa protease cleavage site.
Additionally, His10-hIRE1a cLD and IRE1 LD coding sequences were cloned into pet47b(+) vector
with a preScission protease cleavage site. Hamster BiP with an N-terminal His10-tag was cloned into
pet16b(+) vector, which was modified to introduce a preScission protease site C-terminal to the
His10-tag. For expression of the proteins, the plasmid of interest was transformed into Escherichia
coli strain BL21DE3* RIPL (Agilent Technologies) or Rosetta2 cells (Novagen). Cells were grown in
Luria Broth at 37˚C until OD600 = 0.6. Protein expression was induced with 0.3 mM IPTG, and cells
were grown at 21˚C overnight. For selective labeling, cells were grown according to published pro-
tocols (Tugarinov and Kay, 2004). Briefly, cells were grown at minimal media in D2O supplemented
with deuterated glucose as the primary carbon source. For purification, cells were resuspended in
Lysis Buffer (50 mM HEPES pH 7.2, 400 mM NaCl, 4 mM dithiothreitol (DTT)(or 5 mM b-mercaptoe-
thanol, if a nickel column was used)) and were lysed in an Avestin EmulsiFlex-C3 cell disruptor at
16,000 psi. The supernatant was collected after centrifugation for 40 min at 30,000xg. MBP-IRE1
cLD constructs were purified on an MBP-amylose resin (New England Biolabs) and eluted with 10
mM amylose in Elution Buffer (50 mM HEPES pH 7.2, 150 mM NaCl, 4 mM DTT) after washing the
column with 20 column volumes of Lysis Buffer. The eluate was then diluted with 50 mM HEPES (pH
7.2) buffer to 50 mM NaCl and applied to a MonoQ ion exchange column and eluted with a linear
gradient from 50 mM to 1 M NaCl. The protein was further purified on a Superdex 200 10/300 gel
filtration column equilibrated with Buffer A (25 mM HEPES pH 7.2, 150 mM NaCl, 2 mM tris(2carbox-
yethyl)phosphine (TCEP). The initial purification of His6- and His10-hIRE1a cLD and His10-BiP con-
structs were performed on a His-TRAP column (GE Healthcare), where the protein was eluted with
gradient from 20 mM to 500 mM imidazole. The eluate was purified on a MonoQ column, before
the His6-tag (pet47b+) or His10-tag (pet16b+) were removed by either PreScission protease (GE
Healthcare, 1 unit of enzyme for 100 mg of protein) or FactorXa (NEB, 1 mg of FactorXa per 100 mg
of protein), respectively. The tag removal was performed at 4o C overnight after the protein concen-
tration was adjusted to 1 mg/mL. CH1 domain of IgG was purified under reducing conditions as
described (Feige et al., 2009). Protein concentrations were determined using extinction coefficient
at 280 nm predicted by the Expasy ProtParam tool (http://web.expasy.org/protparam/).
Peptide arrays
Peptide arrays were purchased from the MIT Biopolymers Laboratory. The tiling arrays were com-
posed of 18-mer peptides that were tiled along the CPY*, MPZ, insulin, lysozyme and PTIP sequen-
ces with a three amino acid shift between adjacent spots. In the mutational arrays, peptides were
synthesized to systematically mutate each amino acid in the core region of the CPY*-derived pep-
tide. The arrays were incubated in 100% methanol for 10 min, then in Binding Buffer (50 mM HEPES
pH 7.2, 150 mM NaCl, 0.02% Tween-20, 2 mM DTT) three times for 10 min each. For BiP experi-
ments, ADP and MgCl2 were added to the binding buffer to final concentrations of 1 mM and 5
mM, respectively. The arrays were then incubated for 1 hr at room temperature with 500 nM MBP-
hIRE1a cLD or His10-BiP and washed again three times with 10 min incubation in between the
washes in Binding Buffer to remove any unbound protein. Using a semi-dry transfer apparatus, the
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bound protein was transferred to a nitrocellulose membrane and detected with anti-MBP antiserum
(NEB) or anti-His6 antibody (Abcam). The contribution of each amino acid to hIRE1a cLD and BiP
binding was calculated as described previously (Gardner and Walter, 2011). The peptide arrays
were quantified using Max Quant. The binding intensity in each spot was normalized to max signal
intensity in the peptide array. The peptides with the top 10% binding scores were selected and the
occurrence of each amino acid in these top-binding peptides was calculated. This value is normalized
to their abundance in the arrays (Figure 2A). To calculate experimental error, the amino acid occur-
rences of top binders were calculated for independent replicates. The statistical significance
(p<0.05) is determined using non-paired t-test by the Prism software (Figure 2—figure supplement
1A).
Fluorescence anisotropy
For fluorescence anisotropy measurements, MPZ1 peptide attached to 5-carboxyfluorescein (5-FAM)
at its C-terminus was obtained at >95% purity from ELIM Biopharmaceuticals. For the remaining
peptides (8ab1, MPZ1-N, MPZ1-M, MPZ1-C and MPZ1-N) derivatives were synthesized with 5-FAM
attached to their N-terminus by GenScript at >95% purity. Binding affinities of hIRE1a cLD or IRE1
mutants to FAM-labeled peptides were measured by the change in fluorescence anisotropy on a
Spectramax-M5 plate reader with excitation at 485 nm and emission at 525 nm with increasing con-
centrations of hIRE1a cLD. Fluorescently labeled peptides were used in a concentration range of 50–
100 nM. The reaction volume of each data point was 20 mL and the measurements were performed
in 384-well, black flat-bottomed plates after incubation of peptide with hIRE1a cLD or its mutants
for 30 min at 25o C. Binding curves were fitted using Prism Software (GraphPad) using the following
equation: Fbound = rfree + (rmax- rfree)/(1 + 10((LogK
1/2-X).nH)), where Fbound is the fraction of peptide
bound, rmax and rfree are the anisotropy values at maximum and minimum plateaus, respectively. nH
is the Hill coefficient and x is the concentration of the protein in log scale. Curvefitting was per-
formed with minimal constraints to obtain K1/2 values with high R
2 values. However, as this equation
does not take into account the equilibria between hIRE1a cLD dimers/oligomers, these apperant K1/
2 values do not reflect the dissociation constant.
Microscale thermophoresis experiments (MST)
MST experiments were performed with a Monolith NT.115 instrument (NanoTemper Technologies,
Germany). All experiments were done with the following buffer: 25 mM HEPES pH 7.2, 150 mM
NaCl, 1 mM TCEP, 0.025% Tween-20. hIRE1a cLD was labeled using the Monolith NT Protein label-
ing Kit Red-Maleimide. Labeled protein was used in the measurements at a concentration of 50 nM.
It was mixed with equal volumes unlabeled interaction partner in two-fold serial dilutions. Hydro-
philic-treated capillaries (NanoTemper Technologies) were used for all the measurements. All experi-
ments were performed at 50% LED power and 40-60–80% IR-laser at 25˚C.
AUC sedimentation velocity experiments
Sedimentation velocity experiments were carried out in a Beckman Optima XL-A analytical centri-
fuge at 40,000xg at 20˚C with An-60 Ti rotor. All experiments were performed in buffer containing
25 mM HEPES pH 7.2, 150 mM NaCl, 2 mM DTT. Samples (400 mL) and reference buffer (410 mL)
were loaded into AUC cells for each experiment. Samples of hIRE1a cLD at 5 mM were scanned at
280 nm, whereas hIRE1a cLD at concentrations higher than 25 mM were scanned at 290 nm to pre-
vent detector saturation at high protein concentrations. Data analysis was performed using the SED-
FIT software employing the c(s) method with time invariant and radial invariant noise fitting
(Schuck, 2000). Buffer viscosity was calculated by Sednterp.
NMR experiments
NMR experiments were performed on an 800 MHz Bruker AVANCE-I spectrometer with a TXI Cryo-
probe equipped with an actively shielded Z-gradient at 298.0 K. Samples were buffer-exchanged
into 25 mM phosphate buffer pH 7.2, 150 mM NaCl and 2 mM DTT in 100% D2O on Vivaspin col-
umns (Millipore). The concentration of WT hIRE1a cLD and hIRE1a cLD mutants varied from 25 to
400 mM in 250 mL volume. Samples were placed in a Shigemi advanced NMR microtube. For peptide
and unfolded protein binding experiments, the peptides were dissolved in the same buffer at high
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concentrations (1–2 mM) and titrated in 1:0.5, 1:1 and 1:2 molar ratios. Two-dimensional [13C, 1 H]-
HMQC methyl correlation experiments on 13CH3–Ile hIRE1a cLD were acquired with 86* and 768*
complex points in the 13C and 1H dimensions, respectively. All spectra were processed with TOP-
SPIN 3.2 and analyzed with Sparky.
Attachment of the spin label to MPZ1 peptide and PRE experiments
MPZ1 peptide at 200 mM was labeled with 3-(2-iodoacetamido)-proxyl (Sigma) at the single cysteine,
Cys5 in 25 mM phosphate buffer pH 7.2, 150 mM NaCl in the presence of 2 mM spin-label at 4˚C
for 8 hr. The labeled peptide was then dialyzed in a Slide-a-Lyzer dialysis cassette (Thermo Fisher
Scientific) with 2 kDa cut-off to remove the excess spin-label and to exchange the buffer to deuter-
ated buffer (25 mM phosphate buffer pH 7.2, 150 mM NaCl, 2 mM DTT) for NMR experiments. Con-
trol samples used in the reference experiments contained (1-oxyl-2,2,5,5-tetramethylpyrroline-3-
methyl) methanethiosulfonate spin-label that was treated the same way as the proxyl-labeled pep-
tide. Wild type hIRE1a cLD and quadruple mutant hIRE1a cLD (Leu186Ile, Ile326/334/362Val) and
single mutant Leu186Ile were used in PRE experiments at 75 mM and 100 mM protein concentration
respectively, in the presence and absence of equimolar concentrations of MPZ1-proxyl peptide. We
normalized the PRE effect with the surface exposed area displayed by that isoleucine to exclude
possible contributions from non-specific interactions with the spin label attached peptide (Clore and
Iwahara, 2009). The normalized PRE values are calculated as follows, the solvent accessible surface
area for isoleucines are calculated using the ‘GETAREA’ webserver (http://curie.utmb.edu/getarea.
html, [Fraczkiewicz and Braun, 1998]) based on hIRE1a cLD crystal structure. The maximum solvent
accessible surface by these isoleucines is normalized to one and the normalized values are multiplied
with the PRE effect. The PRE effect is calculated by dividing the intensity of isoleucine signals in the
control experiments with the isoleucine signals in the presence of MPZ1-proxyl peptide.
Cross-linking experiments
10 mM, 20 mM and 50 mM hIRE1a cLD was incubated with 500 mM and 1 mM BS3 cross-linker for 15
and 30 min at room temperature. Same reaction was performed for hIRE1 cLD pre-bound to 50 mM
MPZ1-N for 30 min on ice. The reaction was stopped with the addition of 1M Tris-HCl at pH 8.0 at
end concentration of 50 mM Tris-HCl, and incubated for 10 min at room temperature before running
the SDS-PAGE gel.
LC-MS/MS analysis and cross-linked peptide identification
Cross-linked products were in-gel digested and analyzed by LC-MS and LC-MS-MS as described pre-
viously (Wu et al., 2013; Zeng-Elmore et al., 2014). Briefly, 1 ml aliquot of the digestion mixture
was injected into an Dionex Ultimate 3000 RSLCnano UHPLC system (Dionex Corporation, Sunny-
vale, CA), and separated by a 75 mm  25 cm PepMap RSLC column (100 A˚, 2 mm) at a flow rate
of ~450 nl/min. The eluant was connected directly to a nanoelectrospray ionization source of an LTQ
Orbitrap XL mass spectrometer (Thermo Scientific, Waltham, MA). LC-MS data were acquired in an
information-dependent acquisition mode, cycling between a MS scan (m/z 315–2,000) acquired in
the Orbitrap, followed by low-energy CID analysis on three most intense multiply charged precursors
acquired in the linear ion trap.
Cross-linked peptides were identified using an integrated module in Protein Prospector, based
on a bioinformatic strategy described previously (Chu et al., 2010; Trnka et al., 2014). The score of
a cross-linked peptide was based on number and types of fragment ions identified, as well as the
sequence and charge state of the cross-linked peptide. Only results where the score difference is
greater than 0 (i.e. the cross-linked peptide match was better than a single peptide match alone) are
considered. Tandem MS spectra of cross-linked peptides were manually inspected to ensure data
quality. With the threshold of peptide score and expectation value for oligomer-only cross-linked
peptides, no decoy match was returned.
Lentiviral constructs and transduction
The coding sequence of wild type GFP-tagged IRE1 (Li et al., 2010) was amplified by PCR with
Phsuion polymerase (NEB) and oligonucleotides with engineered restriction sites. The PCR product
was introduced into the Gateway entry vector pSHUTTLE-CMV-TO (kind gift of A. Ashkenazi,
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Genentech and (Gray et al., 2007) atcognate KpnI and EcoRI sites. The hIRE1a-GFP- IF2L mutant
was generated in pSHUTTLE-CMV-TO by site directed mutagenesis of the wild-type sequence. The
resulting clones were recombined into pGpHUSH.puro (kind gift of A. Ashkenazi, Genentech and
[Gray et al., 2007]), a single lentivirus expression vector that allows the doxycyline-regulatable
(TetON) expression of a gene-of-interest. VSV-G pseudotyped lentiviral particles were prepared using
standard protocols using 293METR packaging cells (kind gift of Brian Ravinovich, formerly at MD
Anderson Cancer Center, [Rabinovich et al., 2006]). Viral supernatants were concentrated by filtra-
tion (Amicon Ultra centrifugal filter device, 100 kDa MWCO) and used to infect target cells by cen-
trifugal inoculation (spinoculation) at 2000 rpm inn a Beckman GH3.8 rotor outfitted with plate
carriers for 90 min in presence of 8 ug/mL polybrene. The cells were left to recover overnight follow-
ing infection and were then subjected to puromycin selection as described below.
Cell culture and generation of stable cell lines
IRE1 double-knockout Mouse Embryonic Fibroblasts (MEF) (IRE1a / /IRE1b / ) and wild-type MEFs
(kind gift of D. Ron, University of Cambridge). were grown in DMEM supplemented with 10% fetal
bovine serum, 2 mM L-glutamine, and penicillin/streptomycin. Cells were not tested for the myco-
plasma contamination. Lentiviral-transduced cells were selected with 6 mg/mL puromycin for 72 hr
based on the puromycin concentration defined by the kill curve. Subsequently, a pulse of 25 nM
doxycycline was given to induce expression of the GFP-tagged IRE1 transgenes for 10–12 hr. The
following day, the doxycycline was washed out and pseudoclonal cell populations were selected by
fluorescent activated cell sorting based on GFP expression for both wild-type (hIRE1a-GFP) and IF2L
mutant (hIRE1a-GFP-IF2L mutant) forms of IRE1. The cells were selected in a FACS Aria instrument
(BD FACSAria3), gating for a very narrow GFP expressing population. This procedure ensures selec-
tion of a pseudoclonal population where most cells have similar levels of expression of the transgene
of interest while avoiding typical problems associated with monoclonal selection of IRE1-expressing
cells; namely an aberrant UPR. The pseudoclonal populations were expanded and frozen as source
stocks for experiments.
Live cell imaging of hIRE1a -GFP and hIRE1a-GFP-IF2L mutant
IRE1 double-knockout MEFs (IRE1a / /IRE1b / ) reconstituted with of hIRE1a -GFP or hIRE1a-GFP-
IF2L mutant were split 2 days before imaging onto ibiTreat dishes (ibidi) at 5  104 cells/dish. 25 nM
Doxyccline containing medium was added for 10–12 hr, withdrawn before imaging and replaced
with imaging media consisting of Fluorobrite DMEM (Thermo Scientific), 2.5% FBS, and 5 mM Hepes
at a pH of 7.0 . Cells were imaged at 37oC on a spinning disk confocal with Yokogawa CSUX A1
scan head, Andor iXon EMCCD camera and 40x Plan Apo air Objective NA 0.95 with a 1.5x tube
lens for additional magnification giving 60x final or 100X objective. Images were acquired using 488
nm laser at a rate of one frame per 3 min with 300 ms exposure time for each time point for an
hour. Images were collected after different time points following induction of ER stress by tunicamy-
cin (5 mg/mL) or thapsigargin (100 nM).
Immunofluorescence of hIRE1a -GFP and hIRE1a-GFP-IF2L mutant
IRE1 double-knockout MEFs (IRE1a / /IRE1b / ) reconstituted with of hIRE1a -GFP and hIRE1a-
GFP-IF2L mutant were grown similar to live cell imaging experiments. After stress induction at vari-
ous time points, cells were washed three times with PBS followed by 3 min fixation with 100% meth-
anol, and a three subsequent 5 min washes with PBS. As these fixation conditions kept GFP intact,
immunostaining of hIRE1a for fluorescence imaging was not required. DAPI staining is performed
according to manufacturer’s instructions (Thermo Fisher).
Generation of cDNA and semi-quantitative PCR
Cells exposed to DMSO or thapsigargin (100 nM) or tunicamycin (5 mg/ml) were collected in 0.5 ml
of TRIzol reagent (Life Technologies) from a six well dish and total RNA was extracted following the
manufacturer’s recommendations. To generate cDNAs, 500 ng of total RNA were reverse tran-
scribed using the SuperScript VILO system (Life Technologies) following the manufacturer’s recom-
mendations. The resulting 20 ml reverse transcription reactions were diluted to 10 times to 200 ml
with 10 mM Tris– HCl pH 8.2, and 1% of this dilution was used for multiplex semiquantitative PCR.
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The multiplex PCR was set up using 1 mM of the forward reverese primers, 0.4 units of Taq DNA
polymerase (Thermo Scientific), 0.2 mM of each dNTP, and 1.5 mM MgCl2, in a 20 ml reaction using
the following buffer system: 75 mM Tris–HCl pH 8.8, 20 mM (NH4)SO4, and 0.01% Tween-20. The
oligonucleotide sequences are the following: Hs_XBP1_Fwd: 50 -GGAGTT AAGACAGCGCTTGG-
30; Hs_XBP1_Rev: 50 -ACTGGGTCCAAGTTG TCCAG-30. The PCR products were amplified for 28
cycles and resolved on 3% agarose gels (1:1 mixture of regular and low-melting point agarose)
stained with ethidium bromide.
Protein analysis by Western-Blot
Cells were lysed in SDS-PAGE loading buffer (1% SDS, 62.5 mM Tris-HCl pH 6.8, 10% glycerol).
Lysates were sonicated and equal amounts were loaded on SDS-PAGE gels (BioRad, Hercules, CA).
Proteins were transferred onto nitrocellulose membranes and probed with primary antibodies
diluted in Phosphate-buffered saline supplemented with 0.1% Tween 20% and 5% bovine serum
albumin at 4˚C, overnight. The following antibodies were used: anti-IRE1 (1:1000) (14C10, Cell Sig-
naling Technology, Danvers, MA), anti-GAPDH (1:1000) (14C10, Cell Signaling Technology, Danvers,
MA and anti-phosho IRE1 antibody(1:500). IRE1 anti-phospho antibody is a kind gift of Avi Ashkena-
zi’s group at Genentech. An HRP-conjugated secondary antibody (Amersham, Piscataway, NJ) was
employed to detect immunereactive bands using enhanced chemiluminescence (SuperSignal;
Thermo Scientific, Waltham, MA) detected by Li-Cor instrument (Li-Core Biosciences).
Acknowledgements
We thank the Walter lab members for insightful comments on the manuscript. Purified D131D pro-
tein was a generous gift from Daniel Elnatan and David Agard. We thank Johannes Buchner for CH1
expression plasmid and Linda Hendershot for hamster BiP expression plasmid. We are thankful to
Avi Ashkenazi and David Lawrence for the anti-phosho-IRE1 antibody and pGpHUSH.puro vector.
We thank the MIT Biopolymers Institute for synthesizing the peptide arrays. This work was supported
by NSF CLF #1307367 (to FC). PW is an Investigator of the Howard Hughes Medical Institute.
Additional information
Funding
Funder Grant reference number Author
National Science Foundation CLF #1307367 F Chu
Howard Hughes Medical Insti-
tute
Peter Walter
The funders had no role in study design, data collection and interpretation, or the
decision to submit the work for publication.
Author contributions
G Elif Karago¨z, Conceptualization, Resources, Formal analysis, Validation, Investigation, Visualization,
Methodology, Writing—original draft, Project administration, Writing—review and editing; Diego
Acosta-Alvear, Resources, Methodology, Writing—review and editing, Generated mouse embryonic
fibroblast cell line stably expressing wild type hIRE1a-GFP; Hieu T Nguyen, Formal analysis, Valida-
tion, Investigation, Ran the XL-MS experiments and analyzed the data; Crystal P Lee, Resources,
Methodology, Helped generating mouse embryonic fibroblast cell line stably expressing wild type
hIRE1a-GFP; Feixia Chu, Formal analysis, Supervision, Funding acquisition, Validation, Investigation,
Methodology, Writing;review and editing, Helped the experimental design of cross-linking coupled
to mass spectroscopy experiments (XL-MS), Ran the XL-MS experiments and analyzed the data;
Peter Walter, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Methodol-
ogy, Writing—review and editing; Conceptualization, Supervision, Funding acquisition, Project
administration, Writing—review and editing
Karago¨z et al. eLife 2017;6:e30700. DOI: https://doi.org/10.7554/eLife.30700 25 of 29
Research article Biochemistry Biophysics and Structural Biology
Author ORCIDs
G Elif Karago¨z http://orcid.org/0000-0002-3392-2250
Peter Walter https://orcid.org/0000-0002-6849-708X
Decision letter and Author response
Decision letter https://doi.org/10.7554/eLife.30700.033
Author response https://doi.org/10.7554/eLife.30700.03
Additional files
Supplementary files
. Transparent reporting form
DOI: https://doi.org/10.7554/eLife.30700.032
References
Acosta-Alvear D, Zhou Y, Blais A, Tsikitis M, Lents NH, Arias C, Lennon CJ, Kluger Y, Dynlacht BD. 2007. XBP1
controls diverse cell type- and condition-specific transcriptional regulatory networks. Molecular Cell 27:53–66.
DOI: https://doi.org/10.1016/j.molcel.2007.06.011, PMID: 17612490
Arago´n T, van Anken E, Pincus D, Serafimova IM, Korennykh AV, Rubio CA, Walter P. 2009. Messenger RNA
targeting to endoplasmic reticulum stress signalling sites. Nature 457:736–740. DOI: https://doi.org/10.1038/
nature07641, PMID: 19079237
Balchin D, Hayer-Hartl M, Hartl FU. 2016. In vivo aspects of protein folding and quality control. Science 353:
aac4354. DOI: https://doi.org/10.1126/science.aac4354, PMID: 27365453
Bertolotti A, Zhang Y, Hendershot LM, Harding HP, Ron D. 2000. Dynamic interaction of BiP and ER stress
transducers in the unfolded-protein response. Nature Cell Biology 2:326–332. DOI: https://doi.org/10.1038/
35014014, PMID: 10854322
Bertolotti A, Wang X, Novoa I, Jungreis R, Schlessinger K, Cho JH, West AB, Ron D. 2001. Increased sensitivity
to dextran sodium sulfate colitis in IRE1beta-deficient mice. Journal of Clinical Investigation 107:585–593.
DOI: https://doi.org/10.1172/JCI11476, PMID: 11238559
Bi M, Naczki C, Koritzinsky M, Fels D, Blais J, Hu N, Harding H, Novoa I, Varia M, Raleigh J, Scheuner D,
Kaufman RJ, Bell J, Ron D, Wouters BG, Koumenis C. 2005. ER stress-regulated translation increases tolerance
to extreme hypoxia and promotes tumor growth. The EMBO Journal 24:3470–3481. DOI: https://doi.org/10.
1038/sj.emboj.7600777, PMID: 16148948
Blond-Elguindi S, Cwirla SE, Dower WJ, Lipshutz RJ, Sprang SR, Sambrook JF, Gething MJ. 1993. Affinity
panning of a library of peptides displayed on bacteriophages reveals the binding specificity of BiP. Cell 75:
717–728. DOI: https://doi.org/10.1016/0092-8674(93)90492-9, PMID: 7902213
Bukau B, Weissman J, Horwich A. 2006. Molecular chaperones and protein quality control. Cell 125:443–451.
DOI: https://doi.org/10.1016/j.cell.2006.04.014, PMID: 16678092
Carrara M, Prischi F, Nowak PR, Kopp MC, Ali MM. 2015. Noncanonical binding of BiP ATPase domain to Ire1
and Perk is dissociated by unfolded protein CH1 to initiate ER stress signaling. eLife 4:e03522. DOI: https://doi.
org/10.7554/eLife.03522, PMID: 25692299
Chu F, Baker PR, Burlingame AL, Chalkley RJ. 2010. Finding chimeras: a bioinformatics strategy for identification
of cross-linked peptides. Molecular & Cellular Proteomics 9:25–31. DOI: https://doi.org/10.1074/mcp.
M800555-MCP200, PMID: 19809093
Clore GM, Iwahara J. 2009. Theory, practice, and applications of paramagnetic relaxation enhancement for the
characterization of transient low-population states of biological macromolecules and their complexes. Chemical
Reviews 109:4108–4139. DOI: https://doi.org/10.1021/cr900033p, PMID: 19522502
Cox JS, Shamu CE, Walter P. 1993. Transcriptional induction of genes encoding endoplasmic reticulum resident
proteins requires a transmembrane protein kinase. Cell 73:1197–1206. DOI: https://doi.org/10.1016/0092-8674
(93)90648-A, PMID: 8513503
Cox JS, Walter P. 1996. A novel mechanism for regulating activity of a transcription factor that controls the
unfolded protein response. Cell 87:391–404. DOI: https://doi.org/10.1016/S0092-8674(00)81360-4, PMID:
8898193
Credle JJ, Finer-Moore JS, Papa FR, Stroud RM, Walter P. 2005. On the mechanism of sensing unfolded protein
in the endoplasmic reticulum. PNAS 102:18773–18784. DOI: https://doi.org/10.1073/pnas.0509487102,
PMID: 16365312
Deuerling E, Patzelt H, Vorderwu¨lbecke S, Rauch T, Kramer G, Schaffitzel E, Mogk A, Schulze-Specking A,
Langen H, Bukau B. 2003. Trigger Factor and DnaK possess overlapping substrate pools and binding
specificities. Molecular Microbiology 47:1317–1328. DOI: https://doi.org/10.1046/j.1365-2958.2003.03370.x,
PMID: 12603737
Karago¨z et al. eLife 2017;6:e30700. DOI: https://doi.org/10.7554/eLife.30700 26 of 29
Research article Biochemistry Biophysics and Structural Biology
4
Feige MJ, Groscurth S, Marcinowski M, Shimizu Y, Kessler H, Hendershot LM, Buchner J. 2009. An unfolded CH1
domain controls the assembly and secretion of IgG antibodies. Molecular Cell 34:569–579. DOI: https://doi.
org/10.1016/j.molcel.2009.04.028, PMID: 19524537
Feldman DE, Chauhan V, Koong AC. 2005. The unfolded protein response: a novel component of the hypoxic
stress response in tumors. Molecular Cancer Research 3:597–605. DOI: https://doi.org/10.1158/1541-7786.
MCR-05-0221, PMID: 16317085
Flynn GC, Pohl J, Flocco MT, Rothman JE. 1991. Peptide-binding specificity of the molecular chaperone BiP.
Nature 353:726–730. DOI: https://doi.org/10.1038/353726a0, PMID: 1834945
Fonseca SG, Burcin M, Gromada J, Urano F. 2009. Endoplasmic reticulum stress in beta-cells and development
of diabetes. Current Opinion in Pharmacology 9:763–770. DOI: https://doi.org/10.1016/j.coph.2009.07.003,
PMID: 19665428
Fraczkiewicz R, Braun W. 1998. Exact and efficient analytical calculation of the accessible surface areas and their
gradients for macromolecules. Journal of Computational Chemistry 19:319–333. DOI: https://doi.org/10.1002/
(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W
Fremont DH, Matsumura M, Stura EA, Peterson PA, Wilson IA. 1992. Crystal structures of two viral peptides in
complex with murine MHC class I H-2Kb. Science 257:919–927. DOI: https://doi.org/10.1126/science.1323877,
PMID: 1323877
Gaponenko V, Howarth JW, Columbus L, Gasmi-Seabrook G, Yuan J, Hubbell WL, Rosevear PR. 2000. Protein
global fold determination using site-directed spin and isotope labeling. Protein Science 9:302–309.
DOI: https://doi.org/10.1110/ps.9.2.302, PMID: 10716182
Gardner BM, Walter P. 2011. Unfolded proteins are Ire1-activating ligands that directly induce the unfolded
protein response. Science 333:1891–1894. DOI: https://doi.org/10.1126/science.1209126, PMID: 21852455
Gardner BM, Pincus D, Gotthardt K, Gallagher CM, Walter P. 2013. Endoplasmic reticulum stress sensing in the
unfolded protein response. Cold Spring Harbor Perspectives in Biology 5:a013169. DOI: https://doi.org/10.
1101/cshperspect.a013169, PMID: 23388626
Ghaemmaghami S, Huh WK, Bower K, Howson RW, Belle A, Dephoure N, O’Shea EK, Weissman JS. 2003.
Global analysis of protein expression in yeast. Nature 425:737–741. DOI: https://doi.org/10.1038/nature02046,
PMID: 14562106
Gillespie JR, Shortle D. 1997. Characterization of long-range structure in the denatured state of staphylococcal
nuclease. II. Distance restraints from paramagnetic relaxation and calculation of an ensemble of structures.
Journal of Molecular Biology 268:170–184. DOI: https://doi.org/10.1006/jmbi.1997.0953, PMID: 9149150
Gottstein D, Reckel S, Do¨tsch V, Gu¨ntert P. 2012. Requirements on paramagnetic relaxation enhancement data
for membrane protein structure determination by NMR. Structure 20:1019–1027. DOI: https://doi.org/10.1016/
j.str.2012.03.010, PMID: 22560730
Gray DC, Hoeflich KP, Peng L, Gu Z, Gogineni A, Murray LJ, Eby M, Kljavin N, Seshagiri S, Cole MJ, Davis DP.
2007. pHUSH: a single vector system for conditional gene expression. BMC Biotechnology 7:61. DOI: https://
doi.org/10.1186/1472-6750-7-61, PMID: 17897455
Harding HP, Zhang Y, Bertolotti A, Zeng H, Ron D. 2000. Perk is essential for translational regulation and cell
survival during the unfolded protein response. Molecular Cell 5:897–904. DOI: https://doi.org/10.1016/S1097-
2765(00)80330-5, PMID: 10882126
Heifetz A, Keenan RW, Elbein AD. 1979. Mechanism of action of tunicamycin on the UDP-GlcNAc:dolichyl-
phosphate Glc-NAc-1-phosphate transferase. Biochemistry 18:2186–2192. DOI: https://doi.org/10.1021/
bi00578a008, PMID: 444447
Hetz C, Thielen P, Matus S, Nassif M, Court F, Kiffin R, Martinez G, Cuervo AM, Brown RH, Glimcher LH. 2009.
XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy.
Genes & Development 23:2294–2306. DOI: https://doi.org/10.1101/gad.1830709, PMID: 19762508
Hollien J, Weissman JS. 2006. Decay of endoplasmic reticulum-localized mRNAs during the unfolded protein
response. Science 313:104–107. DOI: https://doi.org/10.1126/science.1129631, PMID: 16825573
Hollien J, Lin JH, Li H, Stevens N, Walter P, Weissman JS. 2009. Regulated Ire1-dependent decay of messenger
RNAs in mammalian cells. The Journal of Cell Biology 186:323–331. DOI: https://doi.org/10.1083/jcb.
200903014, PMID: 19651891
Hotamisligil GS. 2010. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140:
900–917. DOI: https://doi.org/10.1016/j.cell.2010.02.034, PMID: 20303879
Jerabek-Willemsen M, Wienken CJ, Braun D, Baaske P, Duhr S. 2011. Molecular interaction studies using
microscale thermophoresis. ASSAY and Drug Development Technologies 9:342–353. DOI: https://doi.org/10.
1089/adt.2011.0380, PMID: 21812660
Karago¨z GE, Duarte AM, Akoury E, Ippel H, Biernat J, Mora´n Luengo T, Radli M, Didenko T, Nordhues BA,
Veprintsev DB, Dickey CA, Mandelkow E, Zweckstetter M, Boelens R, Madl T, Ru¨diger SG. 2014. Hsp90-Tau
complex reveals molecular basis for specificity in chaperone action. Cell 156:963–974. DOI: https://doi.org/10.
1016/j.cell.2014.01.037, PMID: 24581495
Kimata Y, Oikawa D, Shimizu Y, Ishiwata-Kimata Y, Kohno K. 2004. A role for BiP as an adjustor for the
endoplasmic reticulum stress-sensing protein Ire1. The Journal of Cell Biology 167:445–456. DOI: https://doi.
org/10.1083/jcb.200405153, PMID: 15520230
Korennykh AV, Egea PF, Korostelev AA, Finer-Moore J, Zhang C, Shokat KM, Stroud RM, Walter P. 2009. The
unfolded protein response signals through high-order assembly of Ire1. Nature 457:687–693. DOI: https://doi.
org/10.1038/nature07661, PMID: 19079236
Karago¨z et al. eLife 2017;6:e30700. DOI: https://doi.org/10.7554/eLife.30700 27 of 29
Research article Biochemistry Biophysics and Structural Biology
Lee AH, Iwakoshi NN, Glimcher LH. 2003. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone
genes in the unfolded protein response. Molecular and Cellular Biology 23:7448–7459. DOI: https://doi.org/10.
1128/MCB.23.21.7448-7459.2003, PMID: 14559994
Leitner A, Walzthoeni T, Kahraman A, Herzog F, Rinner O, Beck M, Aebersold R. 2010. Probing native protein
structures by chemical cross-linking, mass spectrometry, and bioinformatics. Molecular & Cellular Proteomics 9:
1634–1649. DOI: https://doi.org/10.1074/mcp.R000001-MCP201, PMID: 20360032
Li H, Korennykh AV, Behrman SL, Walter P. 2010. Mammalian endoplasmic reticulum stress sensor IRE1 signals
by dynamic clustering. PNAS 107:16113–16118. DOI: https://doi.org/10.1073/pnas.1010580107, PMID: 207
98350
Lin JH, Li H, Yasumura D, Cohen HR, Zhang C, Panning B, Shokat KM, Lavail MM, Walter P. 2007. IRE1 signaling
affects cell fate during the unfolded protein response. Science 318:944–949. DOI: https://doi.org/10.1126/
science.1146361, PMID: 17991856
Lu M, Lawrence DA, Marsters S, Acosta-Alvear D, Kimmig P, Mendez AS, Paton AW, Paton JC, Walter P,
Ashkenazi A. 2014. Opposing unfolded-protein-response signals converge on death receptor 5 to control
apoptosis. Science 345:98–101. DOI: https://doi.org/10.1126/science.1254312, PMID: 24994655
Marcinowski M, Ho¨ller M, Feige MJ, Baerend D, Lamb DC, Buchner J. 2011. Substrate discrimination of the
chaperone BiP by autonomous and cochaperone-regulated conformational transitions. Nature Structural &
Molecular Biology 18:150–158. DOI: https://doi.org/10.1038/nsmb.1970, PMID: 21217698
Matsumura M, Fremont DH, Peterson PA, Wilson IA. 1992. Emerging principles for the recognition of peptide
antigens by MHC class I molecules. Science 257:927–934. DOI: https://doi.org/10.1126/science.1323878,
PMID: 1323878
Matus S, Nassif M, Glimcher LH, Hetz C. 2009. XBP-1 deficiency in the nervous system reveals a homeostatic
switch to activate autophagy. Autophagy 5:1226–1228. DOI: https://doi.org/10.4161/auto.5.8.10247, PMID: 1
9855189
Mimura N, Fulciniti M, Gorgun G, Tai YT, Cirstea D, Santo L, Hu Y, Fabre C, Minami J, Ohguchi H, Kiziltepe T,
Ikeda H, Kawano Y, French M, Blumenthal M, Tam V, Kertesz NL, Malyankar UM, Hokenson M, Pham T, et al.
2012. Blockade of XBP1 splicing by inhibition of IRE1a is a promising therapeutic option in multiple myeloma.
Blood 119:5772–5781. DOI: https://doi.org/10.1182/blood-2011-07-366633, PMID: 22538852
Niwa M, Sidrauski C, Kaufman RJ, Walter P. 1999. A role for presenilin-1 in nuclear accumulation of Ire1
fragments and induction of the mammalian unfolded protein response. Cell 99:691–702. DOI: https://doi.org/
10.1016/S0092-8674(00)81667-0, PMID: 10619423
Oikawa D, Kimata Y, Kohno K, Iwawaki T. 2009. Activation of mammalian IRE1alpha upon ER stress depends on
dissociation of BiP rather than on direct interaction with unfolded proteins. Experimental Cell Research 315:
2496–2504. DOI: https://doi.org/10.1016/j.yexcr.2009.06.009, PMID: 19538957
Otero JH, Liza´k B, Hendershot LM. 2010. Life and death of a BiP substrate. Seminars in Cell & Developmental
Biology 21:472–478. DOI: https://doi.org/10.1016/j.semcdb.2009.12.008, PMID: 20026282
Pincus D, Chevalier MW, Arago´n T, van Anken E, Vidal SE, El-Samad H, Walter P. 2010. BiP binding to the ER-
stress sensor Ire1 tunes the homeostatic behavior of the unfolded protein response. PLoS Biology 8:e1000415.
DOI: https://doi.org/10.1371/journal.pbio.1000415, PMID: 20625545
Rabinovich B, Li J, Wolfson M, Lawrence W, Beers C, Chalupny J, Hurren R, Greenfield B, Miller R, Cosman D.
2006. NKG2D splice variants: a reexamination of adaptor molecule associations. Immunogenetics 58:81–88.
DOI: https://doi.org/10.1007/s00251-005-0078-x, PMID: 16470377
Roy A, Kucukural A, Zhang Y. 2010. I-TASSER: a unified platform for automated protein structure and function
prediction. Nature Protocols 5:725–738. DOI: https://doi.org/10.1038/nprot.2010.5, PMID: 20360767
Ru¨diger S, Buchberger A, Bukau B. 1997a. Interaction of Hsp70 chaperones with substrates. Nature Structural &
Molecular Biology 4:342–349. DOI: https://doi.org/10.1038/nsb0597-342
Ru¨diger S, Germeroth L, Schneider-Mergener J, Bukau B. 1997b. Substrate specificity of the DnaK chaperone
determined by screening cellulose-bound peptide libraries. The EMBO Journal 16:1501–1507. DOI: https://doi.
org/10.1093/emboj/16.7.1501, PMID: 9130695
Scheuner D, Song B, McEwen E, Liu C, Laybutt R, Gillespie P, Saunders T, Bonner-Weir S, Kaufman RJ. 2001.
Translational control is required for the unfolded protein response and in vivo glucose homeostasis. Molecular
Cell 7:1165–1176. DOI: https://doi.org/10.1016/S1097-2765(01)00265-9, PMID: 11430820
Schuck P. 2000. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and
lamm equation modeling. Biophysical Journal 78:1606–1619. DOI: https://doi.org/10.1016/S0006-3495(00)
76713-0, PMID: 10692345
Sidrauski C, Walter P. 1997. The transmembrane kinase Ire1p is a site-specific endonuclease that initiates mRNA
splicing in the unfolded protein response. Cell 90:1031–1039. DOI: https://doi.org/10.1016/S0092-8674(00)
80369-4, PMID: 9323131
Street TO, Lavery LA, Agard DA. 2011. Substrate binding drives large-scale conformational changes in the
Hsp90 molecular chaperone. Molecular Cell 42:96–105. DOI: https://doi.org/10.1016/j.molcel.2011.01.029,
PMID: 21474071
Sung SC, Chao CY, Jeng KS, Yang JY, Lai MM. 2009. The 8ab protein of SARS-CoV is a luminal ER membrane-
associated protein and induces the activation of ATF6. Virology 387:402–413. DOI: https://doi.org/10.1016/j.
virol.2009.02.021, PMID: 19304306
Tirasophon W, Lee K, Callaghan B, Welihinda A, Kaufman RJ. 2000. The endoribonuclease activity of mammalian
IRE1 autoregulates its mRNA and is required for the unfolded protein response. Genes & Development 14:
2725–2736. DOI: https://doi.org/10.1101/gad.839400, PMID: 11069889
Karago¨z et al. eLife 2017;6:e30700. DOI: https://doi.org/10.7554/eLife.30700 28 of 29
Research article Biochemistry Biophysics and Structural Biology
Trnka MJ, Baker PR, Robinson PJ, Burlingame AL, Chalkley RJ. 2014. Matching cross-linked peptide spectra: only
as good as the worse identification. Molecular & Cellular Proteomics 13:420–434. DOI: https://doi.org/10.
1074/mcp.M113.034009, PMID: 24335475
Tsuru A, Fujimoto N, Takahashi S, Saito M, Nakamura D, Iwano M, Iwawaki T, Kadokura H, Ron D, Kohno K.
2013. Negative feedback by IRE1b optimizes mucin production in goblet cells. PNAS 110:2864–2869.
DOI: https://doi.org/10.1073/pnas.1212484110, PMID: 23386727
Tugarinov V, Hwang PM, Kay LE. 2004. Nuclear magnetic resonance spectroscopy of high-molecular-weight
proteins. Annual Review of Biochemistry 73:107–146. DOI: https://doi.org/10.1146/annurev.biochem.73.
011303.074004, PMID: 15189138
Tugarinov V, Kay LE. 2004. An isotope labeling strategy for methyl TROSY spectroscopy. Journal of
Biomolecular NMR 28:165–172. DOI: https://doi.org/10.1023/B:JNMR.0000013824.93994.1f, PMID: 14755160
Tugarinov V, Sprangers R, Kay LE. 2007. Probing side-chain dynamics in the proteasome by relaxation violated
coherence transfer NMR spectroscopy. Journal of the American Chemical Society 129:1743–1750. DOI: https://
doi.org/10.1021/ja067827z, PMID: 17249677
Vidal RL, Figueroa A, Court FA, Thielen P, Molina C, Wirth C, Caballero B, Kiffin R, Segura-Aguilar J, Cuervo AM,
Glimcher LH, Hetz C. 2012. Targeting the UPR transcription factor XBP1 protects against Huntington’s disease
through the regulation of FoxO1 and autophagy. Human Molecular Genetics 21:2245–2262. DOI: https://doi.
org/10.1093/hmg/dds040, PMID: 22337954
Walter P, Ron D. 2011. The unfolded protein response: from stress pathway to homeostatic regulation. Science
334:1081–1086. DOI: https://doi.org/10.1126/science.1209038, PMID: 22116877
Wilson IA, Fremont DH. 1993. Structural analysis of MHC class I molecules with bound peptide antigens.
Seminars in Immunology 5:75–80. DOI: https://doi.org/10.1006/smim.1993.1011, PMID: 8504218
Wu B, Peisley A, Richards C, Yao H, Zeng X, Lin C, Chu F, Walz T, Hur S. 2013. Structural basis for dsRNA
recognition, filament formation, and antiviral signal activation by MDA5. Cell 152:276–289. DOI: https://doi.
org/10.1016/j.cell.2012.11.048, PMID: 23273991
Yoshida H, Haze K, Yanagi H, Yura T, Mori K. 1998. Identification of the cis-acting endoplasmic reticulum stress
response element responsible for transcriptional induction of mammalian glucose-regulated proteins.
Involvement of basic leucine zipper transcription factors. The Journal of Biological Chemistry 273:33741–33749.
DOI: https://doi.org/10.1074/jbc.273.50.33741, PMID: 9837962
Yoshida H, Matsui T, Yamamoto A, Okada T, Mori K. 2001. XBP1 mRNA is induced by ATF6 and spliced by IRE1
in response to ER stress to produce a highly active transcription factor. Cell 107:881–891. DOI: https://doi.org/
10.1016/S0092-8674(01)00611-0, PMID: 11779464
Zeng-Elmore X, Gao XZ, Pellarin R, Schneidman-Duhovny D, Zhang XJ, Kozacka KA, Tang Y, Sali A, Chalkley RJ,
Cote RH, Chu F. 2014. Molecular architecture of photoreceptor phosphodiesterase elucidated by chemical
cross-linking and integrative modeling. Journal of Molecular Biology 426:3713–3728. DOI: https://doi.org/10.
1016/j.jmb.2014.07.033, PMID: 25149264
Zhang K, Kaufman RJ. 2008. From endoplasmic-reticulum stress to the inflammatory response. Nature 454:455–
462. DOI: https://doi.org/10.1038/nature07203, PMID: 18650916
Zhang Y. 2008. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 9:40. DOI: https://doi.
org/10.1186/1471-2105-9-40, PMID: 18215316
Zhou J, Liu CY, Back SH, Clark RL, Peisach D, Xu Z, Kaufman RJ. 2006. The crystal structure of human IRE1
luminal domain reveals a conserved dimerization interface required for activation of the unfolded protein
response. PNAS 103:14343–14348. DOI: https://doi.org/10.1073/pnas.0606480103, PMID: 16973740
Karago¨z et al. eLife 2017;6:e30700. DOI: https://doi.org/10.7554/eLife.30700 29 of 29
Research article Biochemistry Biophysics and Structural Biology
